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a hypermetabolic swine model, with our results comparing favorably to 17O2 measurements of absolute
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ABSTRACT
Inhaled Oxygen as a Quantitative Intravascular MRI Contrast Agent
David Thomas Pilkinton
Thesis Supervisor: Ravinder Reddy, PhD

Increasing the fraction of inspired oxygen (FiO2) generates MR contrast by two distinct
mechanisms: increased T2 from deoxyhemoglobin dilution in venous compartments
(blood oxygenation level-dependent effect or BOLD) and reduced T1 from paramagnetic
molecular oxygen dissolved in blood plasma and tissues. Many research and clinical
applications using hyperoxic contrast have recently emerged, including delineating
ischemic stroke penumbra, oxygen delivery to tumors, and functional MRI data
calibration. However, quantitative measurements using this contrast agent depend on the
precise knowledge of its effects on the MR signal – of which there remain many crucial
missing pieces.

This thesis aims to obtain a more quantitative understanding of intravascular hyperoxic
contrast in vivo, with the hope of increasing its precision and utility. Specifically, our
work focuses on the following areas: (1) paramagnetic effects of molecular oxygen
BOLD and arterial spin labeling (ASL) data, (2) degree and temporal characteristics of
hyperoxia-induced reductions in cerebral blood flow (CBF), (3) use of oxygen in
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quantitative measurements of metabolism, and (4) biophysical mechanisms of hyperoxic
T1 contrast.

In Chapter 2, the artifactual influence of paramagnetic molecular oxygen on BOLDmodulated hyperoxic gas studies is characterized as a function of static field strength, and
we show that optimum reduction in FiO2 mitigates this effect while maintaining BOLD
contrast. Since ASL measurements are highly sensitive to arterial blood T1 (T1a), the
value of T1a in vivo is determined as a function of arterial oxygen partial pressure in
Chapter 3. The effect of both the degree and duration of hyperoxic exposure on absolute
CBF are quantified using simultaneous ASL and in vivo T1a measurements, as described
in Chapter 4. In Chapter 5, hyperoxic gas calibration of BOLD/ASL data is used to
measure cerebral oxygen metabolism in a hypermetabolic swine model, with our results
comparing favorably to

17

O2 measurements of absolute metabolism. In Chapter 6, a

model to describe the relationship between CBF, oxygen consumption, and hyperoxic T1
reduction is developed, which allows for a more rigorous physiological interpretation of
these data. Taken together, this work represents several important steps towards making
hyperoxia a more quantitative MRI contrast agent for research and clinical applications.
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Chapter 1: Theory and Technical Challenges of Using Inhaled Oxygen
as an Intravascular MRI Contrast Agent

1.1 Overview
Understanding how oxygen is delivered to and consumed in tissue are central questions
in physiology. Many of the details concerning how these processes occur are still the
subject of ongoing scientific investigation. Adequate oxygen delivery to tissues at a rate
that meets or exceeds its demand is critical for life, and impairments in this process are
centrally important to many diseases, including stroke, cancer, and Alzheimer’s disease.
Therefore, there is a tremendous potential research and clinical benefit in developing
imaging techniques that are sensitive to the delivery and utilization of oxygen in vivo.

Magnetic resonance imaging (MRI) is capable of utilizing a wide variety of modalities to
monitor oxygen physiology in vivo. One important technique to monitor oxygen delivery
and consumption involves the use of hyperoxic (fraction of inspired of oxygen or FiO2 >
0.21) inhalation contrast. The work undertaken in this thesis consists of important steps
towards further developing hyperoxia as a quantitative intravascular contrast agent. But
before discussing this work in detail, several fundamental concepts must be understood,
including: the physical properties of oxygen, the mechanisms of in vivo oxygen delivery
and utilization, the relaxivities of hemoglobin and molecular oxygen, static field shifts
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from oxygen gas, the physiologic effects of hyperoxia, and the applications of hyperoxic
MR contrast.

1.2 Physical Properties of Oxygen
At standard temperature and pressure, oxygen is an odorless, pale blue, diatomic gas with
the molecular formula of O2 (1). Two oxygen atoms are covalently bonded in a spin
triplet configuration. Triplet oxygen is the normal ground state of the O2 molecule and it
has two unpaired electrons occupying two degenerate molecular orbitals (2). In its triplet
form, oxygen is paramagnetic, the property of a material indicating that it generates an
attractive magnetic field in the presence of an external magnetic field.

The

paramagnetism of oxygen is due to its unpaired electrons, which have their own spin
magnetic moments (2).

While gaseous and dissolved oxygen exhibit mild

paramagnetism, liquid oxygen is strongly paramagnetic and can even be held up by a
strong permanent magnet (1).

Oxygen has three naturally occurring stable isotopes:

16

O, 17O, and 18O, with 16O being

by far the most common form with a 99.8% natural abundance level.

18

O is an important

precursor for fluorodeoxyglucose (FDG), which is used in positron emission tomography
(PET). To create

18

F for FDG, enriched water, H2

hydrogen ions in a cyclotron.

17

18

O, is bombarded with high energy

O is the only stable oxygen isotope with a nuclear spin
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(5/2), making it the only directly detectable form of oxygen by NMR. It has been used in
vivo for a direct measurement of regional metabolism, since the formation of H2 17O from
aerobic metabolism is detectable by an increase in the proton transverse relaxation rate.
The metabolic rate of oxygen can then be determined by measuring the rate of formation
of H2 17O (3).

Oxygen has a similar solubility in water to other non-polar, non-chemically reactive
gases. The formation of dissolved oxygen gas in water is well-described by Henry’s law,
which states that, at a constant temperature, the amount of gas that will dissolve into a
liquid is directly proportional to the partial pressure of the gas in equilibrium with the
liquid. The solubility of the gas can be described by the measurement of Henry’s law
constant:

[ 1.1 ]

Oxygen is approximately twice as soluble in water as nitrogen. Temperature is inversely
related to the solubility of oxygen, with about 200C water dissolving approximately twice
the oxygen of 370C water.

The solubility of oxygen in water at 370C is 0.0031

mL/dL/mm Hg. It is also interesting to note that oxygen is approximately four times
more soluble in lipid than in water. The relative lipophilicity of oxygen is due to its
nonpolar structure.
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1.3 Oxygen Delivery and Consumption In Vivo
1.3.1 Cellular Respiration
Since continuous cellular respiration is crucial to the biology of obligate aerobes, a
continuous delivery of oxygen to tissues is necessary for the viability of almost all multicellular organisms. Animals that are not adapted to hypoxia cannot survive for more than
a few minutes without oxygen. Most cellular respiration is aerobic and can be described
as:

[ 1.2 ]

Energy created by respiration is converted to an energy storage molecule, adenosine-5’triphosphate (ATP). The metabolic rate of consumption of oxygen is substantial in
humans, as the body turns over more than its own weight in ATP every day (4).

1.3.2 Oxygen Transport and Hemoglobin
As stated above, the amount of oxygen that can be dissolved in water is relatively small.
Animals have evolved a solution to this problem with the molecule hemoglobin, an ironcontaining oxygen-transport metalloprotein in the red blood cells (RBC) of all
vertebrates. Red blood cells are approximately 95% hemoglobin by dry weight, and
hemoglobin makes up around 35% of total RBC content. Each molecule of hemoglobin
can carry up to four molecules of O2, and approximately 1.34 mL O2 can be carried per
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gram of hemoglobin. At a partial pressure of oxygen of 100 mm Hg, the carrying
capacity of oxygen in the blood is increased by approximately 65 fold over blood plasma
alone. Hemoglobin also carries approximately 10% of respiratory carbon dioxide in the
form of carbaminohemoglobin.

1.3.3 Structure of Hemoglobin and Oxygen Binding
The hemoglobin molecule has a quaternary structure consisting of four globular protein
subunits.

In humans, the most common hemoglobin type is hemoglobin A, which

consists of two α and two β subunits non-covalently bound as a tetramer. These subunits
are structurally similar and approximately the same size. Each subunit has a protein
chain arranged into a set of alpha-helix structural elements, which assemble to form a
globin fold arrangement. In this arrangement, a pocket is formed that tightly binds a
heme group, which consists of a charged atom of iron (Fe) held inside a heterocyclic ring
known as a porphyrin. The iron atom is the site of oxygen binding and it can be in the
Fe2+ or Fe3+ state. Oxygen can only bind in the Fe2+ state, which reversibly oxidizes it to
Fe3+ and transforms oxygen into superoxide.

Due to the structural features of hemoglobin, it exhibits cooperative binding of oxygen.
In general, hemoglobin exists as oxyghemoglobin and deoxyhemoglobin, depending on
whether it is saturated or desaturated with oxygen, respectively.

When an oxygen

molecule binds to hemoglobin, steric conformational changes occur to increase the
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affinity of hemoglobin for additional oxygen molecules on the remaining binding sites.
This results in a sigmoidal or S-shaped hemoglobin oxygen binding curve (Fig. 1.1). The
oxygen binding curve is the relationship between the saturation of oxygen and the arterial
partial pressure of oxygen (PaO2); for human hemoglobin, it is described by the
Severinghaus equation:

[ 1.3 ]
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Figure 1.1. The hemoglobin oxygen binding curve. The curve has a sigmoidal shape
that is due to the cooperative binding of hemoglobin, created through steric
conformational changes induced from binding oxygen molecules.

Hemoglobin has two distinct structural states, a taut form and a relaxed form. The taut
form has lower affinity to oxygen than the relaxed form. Physiological blood factors
including high partial pressure of CO2, low pH, and high 2,3-bisphosphoglycerate levels
favor the taut form, which lowers the affinity for oxygen of hemoglobin and results in a
rightward shift of the hemoglobin-oxygen binding curve. This action assists in offloading oxygen from hemoglobin in the capillaries, where the partial pressure of CO2 is
high and the pH is low. The opposite physiological changes increase the oxygen binding
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affinity and produce a leftward shift of oxygen binding curve, which is important in
assisting the uptake of oxygen in the lungs.

1.3.4 Arterial Partial Pressure of Oxygen and Blood Oxygen Content
When inhaled at normal atmospheric pressure and concentration, the partial pressure of
oxygen (pO2) is approximately 160 mm Hg. Taking water vapor pressure into account,
the pO2 in the trachea is reduced to approximately 150 mm Hg. By the time oxygen
reaches the alveoli, the site of final gas exchange in the lung, the pO2 is approximately
100 mm Hg. This is because the alveolar pO2 represents a balance between the removal
of oxygen by the pulmonary capillaries and the supply of oxygen from the airway.

Total arterial blood oxygen content is the sum of oxygen bound to hemoglobin and
dissolved in the plasma. When PaO2 is 100 mm Hg, hemoglobin is approximately 98%
saturated. Based on its oxygen carrying capacity, the content of oxygen in hemoglobin is
approximately 19.6 mLo2 per dL of blood. The solubility of oxygen in the plasma is
essentially the same as water. Therefore, the oxygen content of the plasma for this PaO2
is 0.31 mLo2 per dL of blood, or 1.6% of the total oxygen content of blood.

As

normobaric oxygen concentration increases to a partial pressure of 760 mm Hg, PaO2 will
increase to approximately 570 mm Hg (the precise maximum level depending on the
particular details of lung ventilation). At 570 mm Hg, content of oxygen in hemoglobin
increases to only about 20.1 mLo2 per dL of blood, but plasma oxygen content increases
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to 1.8 mLo2 per dL of blood. Therefore, the overall increase in the oxygen content of
blood from a PaO2 of 100 to 570 mm Hg is approximately 9.6%. The relationship of
PaO2 to the arterial blood oxygen content (CaO2) is shown in Fig. 1.2. The process is
described in further detail in Chapter 5.

Figure 1.2. The arterial blood oxygen content (CaO2) as a function of arterial
partial pressure of oxygen (PaO2).

1.3.5 Conservation of Mass: Fick’s Principle
The conservation of mass principle indicates that the total amount of oxygen delivered to
the tissue from the arteries must either be consumed by the tissue or must exit via the
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venous blood. This is also known as Fick’s principle, and when concerning oxygen
consumption in the brain, is often stated in the following forms, which are equivalent:

[ 1.4 ]

[ 1.5 ]

where CMRO2 is the cerebral metabolic rate of oxygen in mL of oxygen per 100 g of
tissue per minute, CvO2 is the oxygen content of venous blood, SvO2 is the saturation of
venous blood, and OEF is the oxygen extraction fraction, the difference in saturation of
arterial and venous blood. Based on Fick’s principle, we can calculate the regional
metabolic rate of oxygen consumption in tissue if we know the arterial oxygen content,
the regional blood flow, and its regional venous oxygen content. While blood flow and
venous oxygen concentration must be known locally, it is generally a safe assumption
that the arterial blood oxygen concentration is a global value and the same in all regions.

1.3.6 Hyperoxic Dilution of Deoxyhemoglobin
As can be seen from Eqs. [1.4] and [1.5], if the arterial concentration of oxygen is
increased while metabolism and flow remain constant, the saturation of venous blood
must also increase. If we can assume that hyperoxic gas does not affect the blood flow or
metabolism of oxygen significantly (5), then oxygen can be considered to produce a
change in the venous saturation that is directly proportional to the excess concentration of
oxygen in the arterial blood (6).
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Although there are regional variations in flow and metabolism values at rest, PET studies
using 15O have found that the resting OEF is remarkably stable and consistent throughout
the brain (7). This is important for measurements using the dilution of deoxyhemoglobin
(dHb) with hyperoxia, since, if a local value of OEF can be assumed, then the local
saturation of venous blood can be determined from the blood flow and the arterial oxygen
content.

The concentration of dHb is known to be directly proportional to venous

saturation. If we assume a value of OEF=0.3 (8), a quantitative relationship between
changes in dHb and PaO2, as shown in Fig. 1.3, can be produced. This line of argument
is very important for calibrating BOLD measurements of CMRO2 with hyperoxia and is
discussed more thoroughly in Chapter 5. From Fig. 1.3, we can see that changing the
PaO2 from 100 to 570 mm Hg results in a reduction of deoxyhemoglobin concentration
by more than 20%.
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Figure 1.3. The relative change in the deoxyhemoglobin concentration versus PaO2
(assuming an OEF=0.3 and no change in blood flow or oxygen consumption).

1.4 NMR Relaxation and Paramagnetic MR Contrast Agents
From thermal agitation, molecules undergo random translation and rotational motion, and
the nuclear spins are affected by rapidly fluctuating microscopic magnetic fields from
nearby nuclear and electron paramagnetic spins. These local fluctuating fields provide a
mechanism for spins to return to the thermal equilibrium after they are perturbed by a
radiofrequency magnetic field pulse. A mathematical description of nuclear magnetic
resonance relaxation mechanisms was first developed by Bloembergen and his colleagues
in what is now known as the Bloembergen-Purcell-Pound (BPP) theory (9). In this
theory, time series analysis is used to model the random field fluctuations with an
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exponential autocorrelation function of the form exp(-t/τc), where τc is the correlation
time. The correlation time is of the order of the time a molecule takes to turn through a
radian or translate over a distance comparable to its size. The Fourier transform of the
autocorrelation function is referred to as the spectral density, and it describes the
frequency distribution of the energy of these fluctuating magnetic fields.

Short

correlation times correspond to fast molecular motions, with increased energy at higher
frequencies, while long correlation times correspond to slow molecular motions, with
increased energy at lower frequencies.

Nuclear magnetic relaxation can be separated into two distinct processes, spin-lattice and
spin-spin relaxation. Spin-lattice relaxation is the process by which spins return to
thermal equilibrium from a perturbation by an RF pulse and can be described by a single
time constant, T1. T1 is also referred to as the longitudinal relaxation time because it
determines the rate of approach of the perturbed magnetization back to its equilibrium
position lying parallel to the static magnetic field.

An accurate phenomenological

description of the spin-lattice relaxation is a monotonic exponential recovery process to
the equilibrium magnetization value, which was first described by Bloch (10). Spinlattice relaxation occurs primarily from motions at or near the resonance (Larmor)
frequency, ω0; it is insensitive to low frequencies (<<ω0) and high frequencies (>>ω0).
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Spin-spin relaxation, described by T2, is the process by which nuclei interact with other
magnetic moments to change their phase relative to one another, also known as phase
decoherence. T2 is also called the transverse relaxation time because it reflects the decay
of magnetization lying orthogonal to the static magnetic field. The phenomenological
description of the spin-spin relaxation is a monotonic exponential decay process. Unlike
spin-lattice relaxation, spin-spin relaxation is sensitive to low frequency processes in
addition to those at the Larmor frequency.

Relaxation processes are produced by two distinct physical mechanisms:

magnetic

moments of nuclear and electron spins (i) on the same molecule (intramolecular) and (ii)
on other adjacent molecules (intermolecular). An analysis of the forces between spins
shows that the strength of the interaction is proportional to the inverse of distance
between the spins to the sixth power (11). This means that only close neighbors of a spin
provide a significant contribution to its relaxation process.

The intra- and intermolecular interactions between spins represent different physical
processes. The intramolecular interaction is dominated by the random rotational motion
of the molecule and is characterized by a rotational correlation time. On the other hand,
the random translational motion of neighboring spins from diffusion dominates the
intermolecular interaction, which is described by a translational correlation time (11).
Rotational and/or translational motions of nearby spins described by correlations times
whose inverse is at the Larmor frequency will have the most significant effect on T1. The
	
  
14	
  

	
  
effects on T2 become larger with increasingly slow rotational and/or translational
motions, i.e. longer correlations times. When the motions of neighboring spins are so
rapid that the correlation times are much less than the inverse of Larmor frequency (i.e.
the “extreme narrowing limit”), the effects on T1 and T2 are equal.

This description of the intermolecular contribution to relaxation is not complete,
however, because this interaction depends not only on the transverse correlation time but
also on the time scale of the interaction between spins.

This interaction was first

described by Bloembergen (12) in his account of the anomalous inequality of T1 and T2
in dilute aqueous solutions of the paramagnetic ions Mn2+ and Gd3+. For these ions, the
proton transverse relaxation rates are larger than the longitudinal rates in aqueous
solution due to the spin exchange interaction between the bulk water and the hydration
sphere around the ion. The probability of the water molecule being adjacent to the ion is
larger for these ions than for other paramagnetic ions, such as Fe3+, where the T1 is equal
to T2. By increasing the interaction time of the water and paramagnetic ions, the spectral
density is shifted to lower frequencies. While this process decreases T1 and T2, it has a
larger effect on T2 due to its low frequency sensitivity.

Paramagnetic molecules have magnetic moments that are many orders of magnitude
stronger than nuclear magnetic moments, and through their translational diffusion, they
produce strong intermolecular interactions that dominate relaxation rates of neighboring
nuclei. Since they produce large effects on the relaxation times, paramagnetic molecules
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are valuable sources of MR contrast. The effect of a paramagnetic molecule on the
relaxation rate can be quantified as the relaxivity or r, which is the change in the
relaxation rate per unit of concentration of the contrast agent:

[ 1.6 ]

where i=1,2, Ri = (1/Ti), and c corresponds to the concentration of contrast agent. It
should be noted that this linear description of relaxivity is only an accurate description of
the pure liquids in a single, homogenous compartment. The relaxivity of paramagnetic
contrast agents in tissue is substantially more complex, since the relaxation mechanisms
involve factors such as local inhomogeneities and exchange between multiple
compartments. Despite this fact, the use of this simplified linear model is actually a good
approximation for most paramagnetic contrast agents in tissue, as we will show below.

In summary, we have provided a basic overview of the nuclear magnetic relaxation
processes, with a focus on intermolecular interactions that describe the effects of
paramagnetic molecules. A complete mathematical description of spin relaxation and its
intra- and intermolecular contributions is beyond the scope of this work, but it is
described in detail by the work of Bloembergen, et al. (9,11,12) and Solomon (13). A
more rigorous description of relaxation based on density matrix formalism was developed
by Kubo and Tomita (14), which was further generalized by the work of Gutowsky and
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Woessner (15).

1.5 Blood Oxygenation and Relaxivity of Deoxyhemoglobin
Early in the study of hemoglobin, it was discovered that deoxyhemoglobin was
paramagnetic and oxyhemoglobin was diamagnetic (16). Given that the lowest energy
configurations of oxygen and iron are paramagnetic, discovering that oxyhemoglobin was
diamagnetic was somewhat unexpected. The conclusion to this finding must be that
some physical process occurs in the interaction between oxygen and iron in hemoglobin
to alter the paramagnetism of both species and make their combination diamagnetic. In
-

this case, the low-spin Fe3+ and superoxide anion (⋅O2 ) that form upon oxygen binding to
hemoglobin collectively have two unpaired electrons that couple antiferromagnetically to
give diamagnetic properties. This has been proven true by various experiments (17).

Since deoxyhemoglobin is paramagnetic and oxyghemoglobin is diamagenetic, the
change in the oxygenation of blood can be determined by analyzing its relaxation times.
Deoxyhemoglobin primarily affects the transverse relaxation time. Hemoglobin is a large
molecule at 68 kDa, and under normal circumstances, all deoxyhemoglobin in the blood
is compartmentalized within red blood cells, which are approximately 6 µm in diameter.
These large sizes means deoxyhemoglobin will exhibit a long translational correlation
time due to its slow translational diffusion. This makes deoxyhemoglobin relatively
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ineffective at enhancing T1 relaxation, and quite effective at decreasing T2. Although
there is exchange of plasma water protons with intracellular protons, the red blood cell
membrane limits this process to a significant extent (18).

In fact, an accurate

approximation of the T2 of blood water protons can be made by a physical model that
only considers the difference in the magnetic susceptibility between the red blood cell
and the plasma (19). The difference in susceptibility between fully desaturated red blood
cells and plasma is substantial and is approximately equal to 0.27 ppm, a value accurately
estimated by Pauling in 1936 (16).

Although it is very difficult to develop a precise analytic expression for the transverse
relaxation rate of blood as a function of oxygenation (20), there are accurate models
based on simulations and experimental measurements. An accurate estimation of the
transverse relaxation time can be made by the Monte Carlo simulation of plasma spin
diffusion through the inhomogeneous magnetic fields around desaturated red blood cells
(21). Briefly, such a simulation can be done as follows. First, a set of N desaturated red
blood cells (assuming spherical shape) are randomly distributed in a three-dimensional
space to give a volume fraction equal to hematocrit and the blood oxygen saturation
level. Second, a single proton is placed at a random starting position. For every time
step Δt, this proton is randomly displaced in the x, y, z dimension by a distance
equivalent to the random sample of a normal distribution (mean equal to zero and
standard deviation equal to the √(2DΔt), where D is the proton diffusion coefficient).
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Third, the magnetic field experienced by this proton at this location, ΔBz, is determined
by summing over the fields produced by all of the individual red blood cells according to:
N � �3
�
4π
R
∆Bz =
∆χB0
(3cos2 θi − 1)
3
r
i
i=1

[ 1.7 ]

where ri is the radial distance and θi is the azumithal angle of the proton from the ith red
blood cell.

Fourth, the phase accumulated by the proton in this time interval is

determined by the equation Δθ = γΔBzΔt. Fifth, if there is an RF refocusing pulse(s) in
the measurement, 1800 is added to the phase at the point of refocusing pulse. Sixth, this
process is repeated for the proton over a time scale allowing for sufficient relaxation
decay. This will depend on the field strength, per Eq. [1.7]. Lastly, this process should
be repeated for a sufficiently large number of protons (≥n=10,000), and the phases of all
proton vectors summed to give a signal at each time point. The resulting decay curve can
be fitted to a monoexponential decay, S=exp(-t/T2), to provide a value for T2. This
process can be repeated for different hematocrit and oxygenation levels, as well as static
magnetic field strengths. As illustrated by this model, the transverse relaxation rate will
increase nonlinearly with the static field strength, because the phase accrual of spins in
the same condition is directly proportional to the field strength.

In both simulations and direct experimental measurements, the transverse relaxation rate
versus oxygenation is best described by a quadratic model (22-24):
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(∗)

R2 = A(∗) (1 − Y )2 + B (∗) (1 − Y ) + C (∗)

[ 1.8 ]

where Y is the blood oxygen saturation fraction (where 1 is fully saturated blood) and R2
is 1/T2. R2* is the transverse relaxation rate with a component due to spin dephasing from
macroscopic static field inhomogeneities, an effect which can be generally be eliminated
with RF refocusing. Based on published empirical fits to the constants A, B, and C from
in vitro experiments, we can determine the value of R2 and R2* at arbitrary levels of blood
oxygenation (22,23). Curves of R2 versus venous oxygenation (1-Y) of blood are shown
in Fig. 1.5. R2* shows similar trends in relaxivity to R2, but at higher relaxation rates.
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Figure 1.4. R2 versus oxygen saturation (1-Y) at 1.5, 3, and 4.7 Tesla from Eq. [1.8]
and literature values of constants A, B, and C.

The expected relaxivity in tissue from deoxyhemoglobin concentration changes is
discussed in detail in Chapter 5. As discussed above, the R2 modulation will depend on
both the intra- and extravascular effects of local deoxyhemoglobin concentrations, which
in turn depend on the tissue microstructure. Modeling these processes is much more
difficult than for blood, as it depends on many tissue specific features including average
vessel size, density, and spatial arrangement. In T2*-weighted images, the orientation of
the sample in the magnetic field also has a substantial effect.
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To approximate the scale of the in vivo relaxivity of deoxyhemoglobin in tissues,
consider T2*-weighted images of the brain at 3T. If deoxyghemoglobin were to be
completely diluted out, we would expect to see approximately a 5-9% signal change
across the brain in T2*-weighted gradient-echo echo planar imaging (EPI) with an echo
time of 32 ms (6). Since the change in venous oxygenation is smaller during hyperoxia,
we typically expect to measure approximately a 1-2% signal change in the same setting.
These changes are readily detectable with T2 and T2*-weighted approaches such as echo
planar and fast spin echo imaging that can produce per voxel signal-to-noise ratios
greater than 100:1.

1.6 Relaxivity of Molecular Oxygen in Arterial Blood and Tissue
As discussed above in Section 1.3, the inhalation of hyperoxic gas mixtures dilutes the
concentration of deoxyhemoglobin in the blood by dramatically increasing the
concentration of dissolved oxygen in blood plasma. However, molecular oxygen is itself
a paramagnetic molecule and will influence the relaxation behavior of blood. The effects
of dissolved molecular oxygen on in vivo relaxation times are not as extensively studied
as those for deoxyhemoglobin and other paramagnetic contrast agents, likely because
substantial interest in hyperoxic contrast has only recently emerged. Understanding the
influence of molecular oxygen on arterial blood is particularly important for quantitative
studies of arterial spin labeling, as discussed in Chapters 3 and 4.
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As discussed above in Section 1.4, small paramagnetic molecules contribute to proton
relaxation in aqueous solutions by two distinct mechanisms, translational diffusion of the
paramagnetic molecule and the proton interaction with the hydration sphere of the
paramagnetic molecule (12). The effective correlation time will therefore involve the
combination of the contributions of (i) the translational diffusion rate and (ii) the proton
residence time in the hydration sphere or the electron T1, whichever is shorter (11,25). In
the case of dissolve molecular oxygen, the spin exchange with the hydration sphere is
extremely rapid, so the effective correlation time is the linear combination of the electron
T1 and translational diffusion rate (26). In water, the correlation time of translational
diffusion and the electron T1 are close in value, so both contribute significantly to the
effective correlation time (27). However, the effective correlation time of oxygen is still
very short in dilute aqueous solutions (26), making the contribution of oxygen to T1 and
T2 small and equal (11). For a complete mathematical description of the effect of
dissolved oxygen relaxation of water, we refer readers to the work of Mirhej (27), Parker
and Harmon, (28), and Teng, et al. (26).

In Chapter 3, we measured the longitudinal relaxivity of molecular oxygen and
determined that its plasma relaxivity is approximately 1.6 × 10-4 s-1 mm Hg-1. This
translates into a T1 change in arterial blood at 3T of approximately 150 ms when
breathing pure oxygen. If arterial blood makes up 5% of the measured signal in tissue,
we expect a change in T1 approaching 10 ms – a change that, although small, is readily
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detectable by in vivo T1 mapping approaches (29,30). Although not measured, we expect
the transverse relaxivity of oxygen to be equal to its longitudinal relaxivity based on the
arguments above.

However, since the transverse relaxation time in body tissues is

dominated by interactions with proteins, we do not expect dissolved oxygen to produce
measurable changes to the linewidth in vivo.

The effect of inhaled oxygen on T1 has been used in several studies to provide
information about oxygen delivery and consumption in normal tissues and tumors (3135). Although there have been qualitative attempts to explain the origin of this contrast,
no attempts have been made to relate its T1 relaxivity to blood flow, blood volume, and
oxygen metabolism. We take up this task in Chapter 6, where we attempt to establish
quantitative relationships between the change in T1 during hyperoxia, tissue blood flow,
and oxygen consumption.

1.7 Oxygen Gas and Bulk Static Magnetic Field Shifts
When a material is placed in magnetic field B, a magnetization M (magnetic moment per
unit volume) is induced in the direction of B if the material is paramagnetic. M is
induced opposite to B if the material diamagnetic. M is directly proportional to B:

[ 1.9 ]
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where κ is the unitless volume susceptibility. Differences in magnetic susceptibility
across samples induce static field inhomogeneities. The brain is near large air filled
spaces, which have dramatically different magnetic susceptibility than tissue. Since there
can be no instantaneous change in magnetic fields when crossing these large
susceptibility differences (i.e., Maxwell’s equations must be satisfied), large scale
magnetic field inhomogeneities are created near these boundaries. The spatial extent and
magnitude of these field inhomogeneities increase at stronger magnetic field strengths,
since induced magnetic field differences in the air-filled spaces and tissues also increase.

Due to the paramagnetic and diamagnetic properties of oxygen and nitrogen gas,
respectively, oxygen dominates the magnetic susceptibility of air. When the oxygen
content of inhaled gases increases, bulk susceptibility of the inhaled gas is altered in a
directly proportional manner. The volume magnetic susceptibilities of air and oxygen
gas are opposite in sign and similar in magnitude to tissue; normal air is approximately
3.2 × 10-8 (cgs units) with pure oxygen gas having a susceptibility five times higher at 1.6
× 10-7. A good approximation for tissue susceptibility is water, which is diamagnetic and
has a volume susceptibility of -7.2 × 10-7.

Although a complete physical model of the effect of oxygen gas in the upper airway on
the static magnetic field requires solving Maxwell’s equations as a partial differential
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equation boundary problem, we can predict that the effects will be measurable based on
the large changes in magnetic susceptibility of the gases. The effect of background
magnetic field shifts is generally not considered in hyperoxic contrast studies of the
human brain ((36-39)). However, it is quite possible this will have a significant effect on
measured values, since gradient-echo echo planar imaging (EPI) approaches typically
used in these studies are highly sensitive to local static magnetic field changes. For these
reasons, we set out in Chapter 2 to further investigate the effect of hyperoxic gas
inhalation on the static magnetic field of brain regions around the upper airway as a
function of FiO2 and static magnetic field strength.

1.8 Cerebral Oxygen Consumption, Blood Flow, and Volume During Hyperoxia
Beyond increasing SaO2 and dissolved oxygen in the arterial blood, an increase in the
fraction of inspired oxygen (FiO2) is known to produce a multitude of detectable
biochemical and physiological effects (40,41).

These include altering the partial

pressures of oxygen and carbon dioxide in tissues, changing the binding of carbon
dioxide and oxygen with hemoglobin, as well as changing ventilation and cerebral blood
flow (CBF) (42-45). Although the causes of such effects and their relationships are quite
complex, it is not necessary to fully characterize all of the details of these physiological
processes in order to use hyperoxia as a quantitative MRI contrast agent. What is
essential is to fully characterize the effect of hyperoxia on physiological phenomena that
affect the MR signal during a typical experiment. While hyperoxia produces detectable
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effects on CBF, the magnitude and temporal characteristics of these changes is important
for determining whether or not we can assume that brief oxygen inhalation periods are
pure sources of image contrast with negligible effects on metabolism.

From prior studies, it has been established that oxygen produces a mild reduction in CBF
(5,37,41,43,44,46,47). However, the degree of this reduction and its relationship to FiO2,
as well as the mechanisms that contribute to it, remain controversial and uncertain (37).
Increasing FiO2 in humans is known to lower end tidal CO2, which results in arteriolar
vasoconstriction and a reduction in CBF.

However, oxygen itself also exhibits a

vasoconstrictive effect that is independent of end tidal CO2 (48,49).

This

vasoconstrictive mechanism of oxygen is unclear, but likely stems from lower nitric
oxide activity (50,51). Although the temporal response characteristics of these effects are
also different, they are expected to exhibit reproducible dose-dependent responses in
most physiologic conditions.

Although it has been established that hyperoxia can mildly lower CBF, studies have
shown that hyperoxia has little to no effect on CBV, even at a FiO2 = 1.0 (6,49,52).
Additionally, arterial hypocapnia has been shown to produce minimal effects on the
arterial cerebral blood volume (53). Similarly, hyperoxia has been shown to have no
effect on the resting cerebral metabolic rate of oxygen (CMRO2), even with pure
normobaric hyperoxia (5). However, it is important to note that direct measures of
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CMRO2 changes are difficult to perform, and therefore such changes during hyperoxia
are difficult to rule out. This assumption would best be tested by glucose uptake PET
studies or

17

O2 inhalation MRI studies, yet these have not yet been performed.

Nevertheless, the lack of evidence to the contrary, despite many studies in this area, is a
good indicator that significant changes in oxygen metabolism during hyperoxia are
unlikely. Since metabolic and CBV changes are likely to contribute very minimally to
MR signal during hyperoxic inhalation, the main physiological parameter that is
important is CBF. Hence, if we can characterize the induced temporal changes of CBF
in a dose-dependent manner during hyperoxia, we can correct for its effects on the MR
signal.

1.9 Safety of Inhalation of Hyperoxic Gas Mixtures
Oxygen begins to exhibit toxic effects at a FiO2 ≥ 0.5 or 50 kPa. Fortunately, most nonsevere forms of oxygen toxicity are well tolerated. Oxygen toxicity has its biochemical
basis in the partial reduction of oxygen by one or two electrons to form reactive oxygen
species (ROS), including the superoxide anion (O2-) and the hydroxyl radical (⋅OH).
Increasing the partial pressure of oxygen in tissue with hyperoxia also increases ROS
concentrations in these tissues (54). All the pathogenic mechanisms of these reactive
species are not fully understood (55), but they are known to create damage to cellular
membranes and DNA (56). The body employs antioxidant systems, such as glutathione,
that can neutralize the effects of ROS in tissues (57). However, these defenses are
	
  
28	
  

	
  
overwhelmed at sufficiently high concentrations of reactive species, leading to cellular
damage and potential tissue necrosis (58).

The effects of oxygen toxicity may be classified by the affected organs, namely the
central nervous system, the pulmonary system, or the ocular system. Central nervous
system toxicity is characterized by convulsions and loss of consciousness. This is the
most severe form of oxygen toxicity, but it almost always occurs under hyperbaric
oxygen exposure (>100 kPa). Pulmonary toxicity is characterized by difficulty breathing
and chest pain, which can occur when breathing normobaric or hyperbaric oxygen.
However, this is typically experienced after prolonged exposure times on the order of
several hours to days. Ocular toxicity is characterized by damage to the lens of the eye,
which can lead to myopia or retinal damage causing detachment. Ocular damage can
also occur with normobaric or hyperbaric oxygen exposure, but it is also typically due to
chronic exposure on the order of many hours to days.

Only hyperbaric oxygen exposure generally leads to cerebral and ocular clinical
manifestations. Exposures as short as a few minutes to partial pressures of oxygen
greater that 160 kPa (eight times the atmospheric pressure of 21 kPa) can cause central
nervous system toxicity. While the exact mechanism for central nervous system toxicity
during hyperoxia remains unclear (59,60), it is likely related to the uncontrolled
formation of ROS in the brain (56). In adults, ocular damage occurs primarily through
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damage to the lens. Hyperoxic myopia has been shown to occur in close circuit scuba
diving and in those undergoing repeated hyperbaric oxygen therapy (61).

The

mechanism is an increase in the refractive power of the lens, which is usually reversible
with time.

Since the lungs and respiratory tract are exposed to the highest concentrations of oxygen
during hyperoxia, they are the first areas to show effects of oxygen toxicity. Normobaric
levels of oxygen can cause acute lung damage, beginning with tracheobronchitis or
inflamed upper airways, experienced 4 to 22 hours after exposure to pure normobaric
oxygen after an asymptomatic period (62). At hyperbaric levels of 200-300 kPa, these
effects may begin as soon as 3 hours after oxygen exposure. Small animal experiments
indicate that a decline in lung function can occur as soon as 24 hours after continuous
100% oxygen exposure (63). Diffuse alveolar damage and acute respiratory distress
syndrome can develop after 48 hours at FiO2 = 1.0 (62). Alveolar collapse, known as
atelectasis, can also be induced by hyperoxia and occurs rapidly during 100% oxygen
inhalation.

In this context, known specifically as absorption atelectasis, as oxygen

replaces nitrogen in the alveoli it is absorbed into the blood rapidly, decreasing alveolar
volume and causing alveolar collapse. High partial pressures of oxygen balanced by
nitrogen (i.e., hyperbaric gas) avoid this scenario (62).
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Adult populations that are particularly at risk for oxygen toxicity are those that have been
treated with the chemotherapeutic agent bleomycin or those with chronic obstructive
pulmonary disease. Bleomycin exposure can greatly increase the effects of pulmonary
oxygen toxicity through the role of proinflammatory cytokines IL-18 and IL-1beta (64).
Any hyperoxic exposures should be avoided in these patients. Patients with chronic
obstructive pulmonary disease can experience a clinical condition called carbon dioxide
narcosis when inhaling hyperoxic gas mixtures. Carbon dioxide narcosis is caused by
excessive CO2 retention, and can be at least in part attributed to a reduction in normal
ventilation-perfusion matching and a reduction in hypoxic drive (62). Hyperoxia can
lead to dangerously high levels of CO2 in these patients and its administration should
generally be avoided.

In summary, although oxygen is not entirely devoid of toxicity and contraindications,
most of the danger occurs either at high levels of oxygen exposure (>160 kPa) for short
periods of time or moderate levels (>50 kPa) for long durations. Therefore, most adverse
effects can be avoided by reducing oxygen concentration to minimal levels (FiO2 < 1.0)
and limiting exposure durations. In our studies, the maximum oxygen exposure was
100% oxygen for ten minutes, which is generally considered to be very safe and we also
avoided any adverse events in our healthy adult subjects.
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1.10 Current Applications of Hyperoxic MRI Contrast
There has been emerging research and clinical interest in using oxygen as an
intravascular MRI contrast agent because of a number of attractive features, including its
wide availability, negligible cost, high tolerability, lack of contraindications, minimal
physiologic effects, and rapid wash-in and wash-out times. Most of the studies on
hyperoxic contrast have focused on using oxygen to create an isometabolic dilution of
deoxyhemoglobin and have used T2- and T2*-weighted imaging approaches to measure
this effect. Some of the main techniques that have been developed using this effect are
calibrated simultaneous BOLD/ASL measurement of the relative cerebral metabolic rate
of oxygen (as an alternative to carbon dioxide) (6,38,39), measurements of regional
capillary-venous cerebral blood volume (36), the characterization of the ischemic
penumbra of stroke lesions including its oxygen consumption and spatial extent (65-68),
and the delineation of hypoxic regions in tumors (31,69).

Other techniques have focused on the other contrast mechanism of hyperoxia, the
measurement of T1 reduction from the delivery of excess oxygen to tissues as an indicator
of baseline tissue oxygenation. Although increases in dissolved oxygen are fairly small,
many have been successful in measuring these longitudinal relaxation changes using T1weighted gradient echo and Look-Locker techniques. These studies include: measuring
relative baseline tumor oxygenation (31,33), oxygen delivery and consumption in skeletal
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muscle (70), lung ventilation (29), and oxygen delivery to physiologic fluids including
the CSF and vitreous humor (71).

1.11 Summary of Technical Challenges in Using Hyperoxia as a Quantitative
Intravascular Contrast Agent
Although progress has been made toward the use of hyperoxia as a quantitative
intravascular contrast agent, several technical challenges remain. First, the effect of bulk
oxygen gas on background field inhomogeneities in typical BOLD-modulated studies of
the human brain using gradient echo EPI has not been explored. We expect that the
fields are likely to change substantially in the frontal lobes near the frontal sinus and oral
cavity, due to the large changes in volume susceptibility between air and pure oxygen
gas. Second, although there have been numerous studies regarding the effects of oxygen
on regional CBF using ASL, they do not correct for the effect of T1 changes in arterial
blood plasma. Furthermore, the temporal effects of CBF change as a function of oxygen
exposure duration have also not been studied in detail. Knowledge of these effects is
crucial for any measurement using ASL and hyperoxia simultaneously, particularly for
BOLD/ASL calibrated studies where flow changes significantly affect the calibration.
Third, the use of hyperoxia calibration studies of relative changes in CMRO2 has not
been validated against absolute quantitative measurements of CMRO2. It is unclear to
what extent these techniques contain sources of errors in their model assumptions, which
can only be determined by comparing them to a gold standard. Fourth, although there
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have been various studies using the longitudinal relaxation enhancement of molecular
oxygen to study oxygen delivery and consumption, there have been no attempts to
quantitatively model the effect of T1 on local tissue blood flow and metabolism. If these
techniques are to provide quantitative information concerning the physiological status of
the tissue, it will be crucial to understand these relationships.

1.12 Specific Aims of Thesis Research
Several technical issues remain concerning the use of hyperoxia as a quantitative
intravascular contrast agent. Hence, the focus of this thesis is to address some of these
important issues, namely to: (1) characterize the paramagnetic effects of molecular
oxygen BOLD and arterial spin labeling (ASL) data, (2) determine the degree and
temporal characteristics of hyperoxia-induced reductions in cerebral blood flow (CBF),
(3) investigate the use of oxygen in quantitative measurements of metabolism, and (4)
elucidate the biophysical mechanisms of hyperoxic T1 contrast. It is towards these goals
that we present the following specific aims:

1.12.1 Aim 1: Characterize the effects of molecular oxygen on BOLD-modulated
hyperoxic contrast studies
Standard approaches to measuring BOLD-modulated hyperoxic contrast in the brain,
including gradient echo EPI and other T2*-weighted approaches, are highly sensitive to
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changes in the background static magnetic fields. There have been no attempts in the
literature to establish whether or not field changes induced by bulk changes in the oxygen
concentration of the upper airway near the brain can affect the background field to cause
detectable changes in measured signals. Chapter 2 aims to characterize these effects as a
function of field strength and FiO2.

1.12.2 Aim 2: Determine the change in longitudinal relaxation time of arterial blood
at arbitrary levels of hyperoxia in vivo
Although ASL techniques are very sensitive to T1 of arterial blood, there have been no
studies that attempt to develop an accurate model of arterial blood T1 measurements as a
function of hyperoxia. Toward this end, we set out to produce such a model by making
in vitro and in vivo measurements of the longitudinal relaxivity versus arterial partial
pressure of oxygen. The work in Chapter 3 represents our work toward developing a
complete quantitative model of the longitudinal relaxation time of arterial blood that
depends only on knowledge of the partial pressure of arterial blood at a given FiO2.

1.12.3 Aim 3: Quantify absolute cerebral blood flow during hyperoxia using arterial
spin labeling
Since ASL is quite sensitive to the T1 of arterial blood, a quantification of absolute
cerebral blood flow during hyperoxia requires knowledge of arterial blood T1 as a
function of arterial oxygen concentration. To date, there have been no published studies
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using in vivo measurements of T1 for arterial blood to correct ASL data. In an attempt to
characterize the effect of this variable on measures of CBF, we made simultaneous in
vivo measurements of T1a and CBF during normoxia and hyperoxia under a brief
hyperoxic inhalation, as well as graded hyperoxic inhalation paradigms on a per subject
basis. This work is the focus of Chapter 4.

1.12.4 Aim 4: Implement hyperoxic gas calibration BOLD/ASL measurements of
relative cerebral metabolic rate of oxygen using a hypermetabolic animal
The focus of this aim is to quantify metabolic changes using hyperoxic calibrated
BOLD/ASL fMRI in a hypermetabolic swine model. Metabolic changes in this animal
model were previously studied by our group using gas isotopically-enriched with

17

O2 .

The goal of this study is to cross-validate these absolute metabolic measurements with
the deoxyhemoglobin dilution methods of relative metabolism, as well as to compare the
results of hyperoxia and hypercapnia calibrations. This work is detailed in Chapter 5.

1.12.5 Aim 5: Develop a biophysical model of the dependence of cerebral blood flow
and metabolism on hyperoxia-induced changes in the longitudinal relaxation
rate of tissue
There have been several studies published regarding the effect of elevated partial
pressures of oxygen in the arterial blood on longitudinal relaxation time in normal and
diseased tissue, mostly using tumor models. While these studies show promising contrast
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from the reduction in T1, indicating an increase in partial pressure of oxygen in these
tissue regions, a quantitative understanding of this contrast mechanism has yet to be
developed. Chapter 6 represents an attempt to establish a quantitative understanding of
the relationship between cerebral blood flow, oxygen consumption, and the longitudinal
relaxivity of hyperoxic contrast.
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Chapter 2: Characterization of the Paramagnetic Effects of Molecular
Oxygen on Blood Oxygenation Level-Dependent-Modulated
Hyperoxic Contrast Studies

2.1 Overview
In hyperoxic contrast studies modulated by the blood oxygenation level-dependent
(BOLD) effect, it is often assumed that hyperoxia is a purely intravascular, positive
contrast agent in T2*-weighted images, and that the effects not due to BOLD contrast are
small enough to be ignored. In this chapter, this assumption is reevaluated and nonBOLD effects in T2*-weighted hyperoxic contrast studies of the human brain were
characterized. We observed significant negative signal changes in T2*-weighted images
in the frontal lobes; B0 maps suggest this effect was primarily due to increased intravoxel
dephasing from increased static field inhomogeneity due to susceptibility changes from
oxygen in and around the upper airway. These static field effects were shown to scale
with magnetic field strength. Signal changes observed around the brain periphery and in
the ventricles suggest the effect of image distortions from oxygen-induced bulk B0 shifts,
along with a possible contribution from decreased T2* due to oxygen dissolved in the
cerebrospinal fluid. Reducing the concentration of inhaled oxygen was shown to mitigate
negative contrast of molecular oxygen due to these effects, while still maintaining
sufficient BOLD contrast to produce accurate measurements of cerebral blood volume.
This results of this work serve to outline limits in which studies of the human brain using
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hyperoxic T2* contrast can be considered to avoid the artifactual effects of paramagnetic
oxygen and be entirely due to deoxyhemoglobin dilution.

2.2 Introduction
As discussed above in Chapter 1, the inhalation of hyperoxic gas mixtures is known to be
an effective positive contrast agent in T2*-weighted images (53,72). To summarize the
process again briefly, an elevated inspired fraction of oxygen (FiO2) causes excess
molecular oxygen to dissolve in the blood plasma in the lungs. The excess oxygen in the
plasma is then delivered to capillaries, where it diffuses into the tissues preferentially to
the oxygen bound to hemoglobin.

The deoxy-/oxyhemoglobin ratio and the

paramagnetism of the blood (blood oxygenation level-dependent, or BOLD, effect) are
subsequently decreased, resulting in an increase in signal on T2*-weighted images. The
T2* contrast generated in a given voxel is dependent on the capillary-venous blood
volume in that voxel and the degree to which the concentration of deoxyhemoglobin
changes in the capillary-venous blood (72).

For oxygen to be considered as a purely intravascular contrast agent in T2*-weighted
images, it must have minimal effects on the MR signal that are not due to the dilution of
deoxyhemoglobin. As covered in Chapter 1, molecular oxygen dissolved in the blood
has a detectable T1 relaxivity (73), and molecular oxygen has been shown to be effective

	
  
39	
  

	
  
as a T1 contrast agent in body fluids (71,74), displaying a fast wash-in of a significant
concentration of molecular oxygen into these tissues. Unless T1-weighting is completely
eliminated by the imaging sequence approach, it could present a possible confounding
factor in these studies.

Another important effect is the disruption of the static magnetic field (B0) in the frontal
lobes of the brain due to the influence of paramagnetic gaseous oxygen in the upper
airway. This effect has not yet been characterized or considered in hyperoxic contrast
studies of the human brain (6,38). The physical argument for this effect was covered in
Chapter 1. To summarize, gaseous nitrogen is diamagnetic, while gaseous oxygen is
weakly paramagnetic. However, since the magnetic susceptibility of gaseous oxygen is
more than 300 times that of gaseous nitrogen (75), the magnetic properties of air are
dominated by oxygen. The volume magnetic susceptibility of air and of oxygen are
therefore approximately equal in value and opposite in sign. The inhalation of FiO2 = 1.0
will make the frontal sinuses approximately five times more paramagnetic than air,
further increasing the difference in magnetic susceptibility at the air-tissue interface.
This will substantially increase the static field inhomogeneity in surrounding brain
regions, leading to decreased signal in T2*-weighted images, distortions in echo-planar
imaging (EPI) acquisitions, and shifts in slice locations.
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In this study, the paramagnetic effects of molecular oxygen on typical BOLD-modulated
T2*-weighted gradient echo EPI studies in the human brain have been characterized. The
degree of negative contrast in tissue specific compartments and regions was also
examined. The effects of inhaled oxygen on the static field were characterized by the
measurement of the difference in B0 maps during normoxia and hyperoxia at 3T and 7T
field strengths. We have shown that the degree of static field inhomogeneity increases
with inhaled oxygen concentration and with increasing field strength. Furthermore, we
demonstrate that a reduction in the concentration of inhaled oxygen significantly reduced
non-BOLD T2* signal changes, while maintaining adequately high contrast-to-noise from
the BOLD effect for accurate CBV calculation.

2.3 Materials and Methods
2.3.1 Gas Delivery and MRI Hardware
All experiments involving humans subjects were done under protocols approved by our
Institutional Review Board, and signed, informed consent was obtained from each
volunteer. All images were collected on a whole-body clinical 3T MRI scanner (Siemens
Trio; Siemens Healthcare, Erlangen, Germany) with a body coil transmitter and 8channel receiver head coil, except for one dataset collected on a whole-body 7T system
(Siemens Magnetom) with a transmit-receive circularly-polarized head coil. For all
experiments, medical air, oxygen, or hyperoxic mixtures were delivered to the subject
with a nonrebreathing mask fitted tightly over the nose and chin, running at a flow rate of
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40 L/min from an air/oxygen blending device capable of delivering precise FiO2 values
of 0.21-1.0 at high flow rates (Precision Medical Inc, Northampton, PA, Model PM5300).
A high flow rate was used to ensure that normal resting maximum peak inspiratory flow
rates were exceeded (76), thus eliminating any entrainment of room air upon inhalation.
The magnet bore fan was run at maximum to ensure that gases did not build up around
the subject.

2.3.2 Hyperoxic Challenge Paradigm
For all hyperoxic challenge experiments, a baseline – stimulation – rest paradigm was
used.

To examine the positive and negative contrast effects across the brain, an

experimental paradigm lasting twenty-seven minutes was performed on one normal,
healthy male volunteer (28 years old).

A baseline three-minute period of normoxia

(FiO2 = 0.21) was followed by two cycles of a six-minute hyperoxic stimulation	
   period	
  
FiO2 = 1.0 and six-minute rest period of FiO2 = 0.21.

2.3.3 MRI Sequence Parameters
During the experiment, continuous whole-brain echo-planar imaging (EPI) data were
collected with the following sequence parameters: FOV: 220 x 220 mm, 128 x 128
matrix, TE/TR: 29/2000 ms, 22 slices, slice thickness: 5 mm, 1 mm slice gap, FA: 900.
In addition to the EPI acquisitions, a high-resolution structural T1-weighted MP-RAGE
scan with 1 x 1 x 1 mm3 voxel size and a whole-brain dual-echo 3D GRE with phase
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reconstruction and 2 x 2 x 2 mm3 voxel size (for B0 mapping) were performed at the
beginning of the experiment to allow for unwarping, structural coregistration, and tissue
segmentation of the EPI data. To characterize the positive and negative contrast effects
as a function of the level of hyperoxia, the same whole-brain EPI data, structural images,
and B0 maps were collected on a set of normal, healthy volunteers (N=6, three male
subjects, age range 28-32 years). All subjects were imaged with experimental paradigm
lasting 27 minutes similar to the one above, except two different FiO2 levels were used.
In this case, a baseline three-minute period of normoxia (FiO2 = 0.21) was followed by a
six-minute mild hyperoxic stimulation	
  period	
  of	
  FiO2 = 0.5, a six-minute rest period of
FiO2 = 0.21, a six-minute hyperoxic stimulation	
   period	
   of	
   FiO2 = 1.0, and a second sixminute rest period of FiO2 = 0.21.

To characterize changes in B0 occurring as a function of the level of hyperoxia, the same
experimental paradigm was performed again while sagitally-oriented whole-brain
continuous dual-echo 3D GRE phase images were acquired for three of the six subjects
following the final normoxic rest period. The sequence parameters were: FOV: 256 x
256 x 160 mm, 128 x 128 x 80 matrix, TE1/TE2/TR: 3/7/12 ms, 6/8 partial Fourier factor
(phase and slice), and FA: 70. The total acquisition time of each 3D GRE image was 72
seconds, allowing five whole-brain B0 maps to be acquired during each stimulation and
rest period. To characterize changes in B0 during hyperoxia as a function of the static
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field strength, this same B0 mapping experiment at different FiO2 levels was performed at
7T for one of these subjects.

2.3.4 Data Analysis
All data were processed using the FMRIB Software Library (FSL) Tools (77). The EPI
data were motion corrected and unwarped using a software package designed to process
intramodal MRI time series data (FEAT) (78).

Each phase image was unwrapped

separately using an automatic phase unwrapping algorithm (PRELUDE) (77).

The

structural images were segmented into masks of three tissue types – CSF, gray matter,
and white matter – using an automatic tissue segmentation algorithm (FAST) (79). The
structural images and their respective masks were co-registered to the EPI data using an
automatic affine registration algorithm (FLIRT) (80). This tool was also used for motion
correction of the series B0 maps by co-registering all magnitude volumes and applying
the affine matrix to the phase data.
Final analysis of all the datasets was performed using custom scripts written in MATLAB
(MathWorks, Inc.). All statistical tests used the Student’s paired t-test; all reported values
and error bars on plots were in mean ± SD. For each six minute epoch of each dataset,
the EPI data from the first three minutes or the first two B0 maps were discarded to allow
the intravascular levels of oxygen to reach a steady state (37). For the first experiment
described, data from all normoxia and hyperoxia epochs were averaged and compared.
For the experiment comparing elevated FiO2 levels, the baseline values of the first
	
  
44	
  

	
  
hyperoxic epoch were obtained from the mean of the first and second normoxia epochs,
and, in the same manner, the second and third were used for the second hyperoxic epoch.
This was done to mitigate signal drift effects. The unwrapped phase datasets were
subtracted and divided by the echo time difference and converted to relative B0 maps in
ppm. The coregistered tissue segmentation masks were multiplied by the unwarped EPI
data to obtain values for CSF, gray matter, and white matter regions across the brain.

2.3.5 Calculation of Regional Cerebral Blood Volume
Regional capillary-venous CBV values were calculated according to the method from
Bulte, et al. (36), whereby the signal enhancement in tissue is normalized to the signal
from a pure vein voxel:

[ 3.1 ]

where n is the number of signal voxel ratios measured after reaching the steady state;
h=(1 - Hct) / (1 - 0.85 x Hct) accounts for the difference in the hematocrit between the
large and small vessels; ρ = 1.04 ml/g is the tissue density; Stissue,j and Svein,j are the signal
measurements made in tissue voxels and a pure vein voxel during hyperoxia; Stissue,0 and
Svein,0 are the baseline signals from each tissue voxel and a pure vein voxel.
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2.4 Localization of Hyperoxia-Induced Positive and Negative EPI Signal Changes
Figure 2.1 provides an example of typical positive (Fig. 2.1b) and negative (Fig. 2.1c)
percent signal change from baseline with 100% oxygen inhalation, along with
coregistered structural images. Positive contrast can be seen across gray matter, with
large veins showing the most contrast. Well-defined regions of negative signal change
can be seen in regions around the frontal sinus as well as in superior slices, but do not
seem to be associated with a particular tissue compartment. Coherent negative contrast is
clearly visualized in the ventricles and large sulci, i.e. specific tissue compartments
known to contain CSF (compare visually to segmentation of CSF in Fig. 2.3, below).
Figure 2.1d shows the clear negative modulation upon oxygen inhalation of the signal in
voxels near the frontal sinuses and in the CSF.
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Figure. 2.1. Percent signal change from baseline upon FiO2=1.0. Both positive (b)
and negative (c) percent signal changes from baseline occur coherently in specific
compartments of the brain, shown clearly in the coregistered MP-RAGE images (a).
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The red arrows point to the negative T2*-contrast effect of the disruption of the B0
field in the frontal lobes from gaseous oxygen in the sinuses and nasal cavity, along
with associated long range static field disruptions in superior-posterior parietal
lobes.

The green arrows illustrate the effects of the reduction in transverse

relaxation times from dissolved molecular oxygen in the CSF; major ventricles and
sulci are clearly outlined in the negative signal change images. Voxels at the blue,
red, and green crosses represent tissue, B0-affected, and CSF regions, respectively;
signal values at these voxels are plotted as percent difference from baseline versus
time at the blue squares (tissue), red triangles (B0-affected), and green diamonds
(CSF) (d). The blue regions represent the two 100% oxygen inhalation epochs. The
values of the B0-affected voxel have been scaled down by a factor of 0.1 for clarity.

2.5 Hyperoxia-Induced Negative EPI Signal Changes versus FiO2
Figure 2.2b, c shows the percent negative contrast from baseline upon inhalation of FiO2
= 1.0 and 0.5, respectively, from five contiguous slices chosen to cover the ventricles and
the frontal lobe regions just superior to the frontal sinus and nasal cavity. The signal
intensities in these images are scaled in the same manner. In addition to substantial
negative contrast centered around the frontal lobes and regions of high CSF, there are
significant (although less coherent) negative signal changes across the brain in white and
gray matter. A distinct reduction in the negative contrast is visualized in all regions at the
lower FiO2 level.

Figure 2.3 shows a representative slice of coregistered tissue
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segmentation masks from each tissue type along with the associated EPI slice. As shown,
the high T1 contrast between these tissue types allows robust segmentation.

Figure 2.2. Comparison of percent negative signal change from baseline for FiO2 =
1.0 (b) and 0.5 (c) with their associated EPI images (a).

Note the significant

reduction in negative contrast across the brain, particularly in the frontal lobe
regions (red arrow) and in the ventricles and major sulci (green arrow).
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Figure 2.3. Tissue masks of cerbrospinal fluid (b), gray matter (c), and white matter
(d) with a registered, unwarped EPI image (a). Tissue segmentation was performed
using an automated tissue segmentation algorithm with a high resolution T1weighted image. The tissue masks were then registered to unwarped EPI data with
an automatic affine registration algorithm.

2.6 Measurement of Hyperoxia-Induced B0 field Perturbation versus FiO2
Figure 2.4 shows results from the subject imaged at 3T and 7T field strengths. Figure
2.4a shows a sagittal cut from 3D relative B0 maps in parts-per-million (ppm) at baseline
at 3T and 7T. The difference in the relative B0 maps between the hyperoxic states at 3T
and 7T is shown in Fig. 2.4b,c. In the frontal lobes near the nasal cavity, more than 0.1
ppm increase in the B0 field was observed during 100% oxygen inhalation at 3T. Similar
changes in the B0 field were measured at 3T in the other two subjects (data not shown).
In the dataset shown, additional static field changes were observed during FiO2 = 1.0 in
superior, posterior, and inferior brain regions far from the nasal cavity (Fig. 4b, top).
Negative signal changes were observed in the EPI acquisitions in the same subject (Fig.
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1c) near these same superior and posterior brain regions showing these additional static
field changes. However, these static field effects were not observed in all subjects.
During 100% oxygen inhalation at 7T, a large region of more than 0.1 ppm increase in
the static field extends past the frontal lobes into the parietal and temporal lobes. At each
field strength, these effects remain present during 50% oxygen inhalation, but to a much
lesser extent (Fig. 4c). The relative change in the static field at different oxygen levels
and field strengths is shown in Fig. 2.4d,e as a change in the normalized relative B0. This
shows that the B0 values superior to the nasal and oral cavities changed approximately
twice as much in FiO2 = 1.0 versus 0.5 at each field strength, and that relative B0 changes
are approximately twice as high at 7T versus 3T. It should be noted, however, that the
results shown here are not from a representative subject, but rather from the one subject
tested at both field strengths. Table 2.1 quantifies the negative contrast in each tissue
type for all (N = 6) subjects as the mean percent of the total voxels in that region that
show a negative (< 0) percent change from baseline. Statistically significant reductions
in the percent of negative voxels for all tissue types are produced at the lower FiO2 level,
with an average overall reduction of 14.1%.
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Figure 2.4. Baseline B0 maps and change in B0 after different levels of oxygen
inhalation at 3T and 7T. Baseline relative B0 maps (ppm) (a) during air breathing
at 3T (top row) and 7T (bottom row). Change in the relative ΔB0 (ppm) maps from
baseline during FiO2 = 1.0 (b) and 0.5 (c) at 3T (top row) and 7T (bottom row). Note
that the effects of the static field extend beyond the frontal lobe region at both field
strengths. The yellow boxes in the top and bottom rows of (a) mark rectangular
regions of interest that are plotted in (d) and (e), respectively, as normalized relative
B0 values versus time for FiO2 = 0.5 oxygen (light blue region) and 1.0 (dark blue
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region) epochs. Normalized B0 values are normalized voxel-by-voxel division of
every B0 map by the value of the first B0 map. Note the substantially larger static
field disruptions at 7T.

Table 2.1. Mean Percent Negative Voxels for All Subjects within Specified Tissue
Regions for FiO2=1.0 and 0.5
FiO2=1.0

FiO2=0.5

p-value

CSF

36.5 ± 5.3

24.1 ± 3.4*

<0.001

White Matter

41.2 ± 7.9

25.0 ± 3.4*

<0.002

Gray Matter

26.4 ± 6.0

12.9 ± 2.3*

<0.01

All Regions

34.7 ± 7.6

20.6 ± 8.8*

<0.001

2.7 CBV Measurement Accuracy at Low FiO2
Figure 5a,b demonstrates that the BOLD contrast is lower in FiO2 = 0.5, but the final
values of CBV computed in Figure 5c,d are very close to those calculated FiO2 = 1.0.
The values in Table 2.2 confirm this, with the mean global CBV values at FiO2 = 0.5
being somewhat higher than those at FiO2 = 1.0, although this difference was not found to
be statistically significant. The values of CBV in gray matter and white matter measured
here are in close agreement with those found in the previous implementation of this
technique (36).
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Figure 2.5. Percent difference and CBV maps in mL/100 g tissue calculated
according to Eq. 1. Positive percent difference from baseline is shown for FiO2=1.0
(a) and 0.5 (b). Despite the reduced signal enhancement of the lower FiO2, there still
remains adequate BOLD contrast to allow for very similar CBV values for FiO2 =
1.0 (c) and 0.5 (d), made possible by the process of normalization to a pure vein
voxel (sagittal vein) in each dataset.
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Table 2.2. Mean Global CBV Values (mL / 100 g) for All Subjects Measured with
100% and 50% Inhaled Oxygen
FiO2=1.0

FiO2=0.5

Gray Matter

3.87 ± 0.43

3.95 ± 0.62

White Matter

2.41 ± 0.36

2.49 ± 0.58

2.8. Chapter Discussion
In this study, the paramagnetic effects of molecular oxygen in T2*-weighted hyperoxic
contrast studies at different FiO2 levels have been characterized.

Of particular

importance, we have characterized the effect of increased FiO2 on static field
inhomogeneity, and we have demonstrated the field strength dependence of this
phenomenon. These effects can produce signal changes that are equal to or greater than
the expected BOLD changes; therefore, it is not accurate to assume that hyperoxia is a
purely intravascular source of image contrast in all brain regions. It may have been
difficult to observe these effects in other studies of hyperoxic contrast because of the use
of lower resolution EPI data, spatial filtering in post-processing, or because the slices
acquired avoided the frontal sinuses or the ventricles (6,36,38). Also, since large voxels
and spatial blurring kernels are commonly used, any negative changes may have been
obscured, since BOLD contrast dominates in most brain regions.
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It should be noted that the strength of the conclusions concerning the field-dependent
effects are limited, since only a single subject was studied at both field strengths.
However, the static field measurements made were found to be very stable during
normoxia in all subjects studied, and the B0 changes observed during hyperoxia at both
field strengths were demonstrably large. Altogether, this provides reasonable grounds for
confidence in the accuracy of these results.

There are several potential non-BOLD sources of signal changes during hyperoxia that
present potential confounding variables in BOLD-modulated hyperoxic contrast studies
of the brain. Substantial changes in B0 in the frontal lobes during hyperoxia suggest an
increase in the paramagnetism of the upper airway directly underneath the brain from
increased local molecular oxygen concentration. Oxygen gas in other nearby spaces,
such as in the mask itself, is also likely to have contributed to the observed effect. The
paranasal sinuses may also play a role, but are less likely to substantially change their
oxygen concentrations during the short inhalation epochs used in this study, as gas
exchange between the nasal cavity and sinuses is slow (81). It is also possible that
oxygen in the lower airway, including the lungs, played a role in changing the static field
during hyperoxia, despite its relatively large distance from the brain (82). Gas in the
lower airway would be expected to produce static field changes that are poorly localized
and affect the entire brain. However, the large (> 0.1 ppm) B0 changes observed in this
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study were well-localized to the anterior and inferior brain regions near the nasal and oral
cavities. Static field changes in other parts of the brain were found to be substantially
smaller, and consistent effects were not observed across subjects. Although it seems
reasonable to conclude that the effects of oxygen in the upper airway dominate the static
field changes in the brain over contributions from the lower airway in the frontal lobes, it
is possible that smaller static field changes occur across the brain during hyperoxia from
oxygen gas in the lungs.

Increased static field inhomogeneity significantly increases intravoxel phase dispersion in
all directions in T2*-weighted EPI acquisitions, which is most likely the main mechanism
of the observed decrease in the signal in the frontal lobes. Static field changes also create
significant image distortions and shifts in EPI acquisitions in the phase encode and
through-slice directions. It has been shown in prior studies that changes in lung magnetic
susceptibility can create image distortions and shifts that cause either negative or positive
signal changes (depending on image orientation), with the most significant effects
occurring at the edges of image intensity (82). These effects are very sensitive to small
changes in the static field, and may be a significant source of signal changes observed at
a distance from the frontal lobes, especially the periphery of the brain in the EPI
acquisitions (see Figs. 1 and 2).
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The CSF also appears to show reduced signal intensity in the EPI acquisitions. The
reason for these changes is somewhat less clear. If dissolved oxyen was present in these
regions, increased signal intensity would be expected from reduced T1. Based on the
arguments in Chapter 1, the transverse relaxivity of molecular oxygen is likely to be
extremely small, even if oxygen were interacting with large proteins. However, it is
possible that this could affect the measured signal intensities near the ventricles and sulci
if the oxygen concentration were very high during hyperoxia, as CSF constitutes a very
large percentage of the voxel signal intensity. Although the transverse relaxation of
arterial blood also decreased with hyperoxia (73), arterial cerebral blood constitutes less
than 3% of tissue voxel volume (83) and signal reductions due to this effect are likely to
be much less significant. It should be noted that B0 shifts may contribute substantially to
any signal changes measured in the CSF-filled spaces in the frontal lobes or at the
periphery of the brain. Furthermore, for the reasons discussed in the previous paragraph,
CSF regions across could show negative contrast due to global field shifts from changing
in the oxygen concentration in the lungs, since CSF represents an image intensity
boundary (82). We observed consistent signal reductions in the lateral ventricles in the
center of the brain during hyperoxia (see Fig. 2.1), away from substantial image intensity
edges and where B0 shift effects are likely to be minimal, lending support to the idea that
there is a subtle global effect from hyperoxia inhalation.
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Reduced FiO2 levels have been shown here to be effective in reducing the non-BOLD
relaxation effects of inhaled oxygen. This adds further support to the physiological
arguments for the use of lower FiO2 (37) to reduce effects not related to BOLD-based
signal modulation. Although the total percent of voxels showing negative signal change
decreased with a lower level of hyperoxia, the percent signal increase from the BOLD
effect in capillaries and veins decreased with lower FiO2. Therefore the beneficial effect
of the decrease in negative contrast with lower FiO2 is mitigated somewhat by the
decreased BOLD response.

However, despite the reduced BOLD contrast, the

correspondence between values of CBV for FiO2 = 0.5 and 1.0 measured in this study
indicates that 50% oxygen inhalation exceeds the contrast-to-noise threshold necessary to
produce precise and accurate CBV values. The relative effectiveness of FiO2 = 0.5 may
also be because a significant fraction of the excess oxygen carried to the capillaries under
hyperoxia is from the increase in the saturation of the arterial hemoglobin, since it is not
completely saturated under normal physiologic conditions (84). Furthermore, oxygen is
known to modestly decrease the cerebral blood flow as a function of increased FiO2 (37),
which acts to reduce some of the expected increase in BOLD signal from the use of a
higher FiO2. It should also be noted that accurate results for CBV measurement may be
produced at an FiO2 less than 0.5. The practical minimum FiO2 for a given experiment
will likely depend on the required contrast-to-noise ratio, which in turn will depend on
several experimental parameters, including the duration and number of the inhalation
epochs, the static field strength, and the signal-to-noise ratio of the imaging approach.
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Several additional strategies could be pursued to reduce or eliminate the non-BOLD
effects of hyperoxic contrast. It is theoretically possible to significantly reduce the
distortion and dephasing effects due to static field alterations by acquiring a three
dimensional B0 map and additional reference scans to characterize the in-plane and
through-plane EPI point spread function in both the normoxic and hyperoxic states (85).
However, these correction methods require substantial increases in the scan time, are
computationally intensive, and are themselves prone to many artifacts and errors, making
their implementation in brief hyperoxia protocols impractical.

Although it is not

physically possible to recover signal from spins that is completely lost due to intravoxel
dephasing, it is possible to deconvolve the contribution to T2* of a through-slice gradient
with a detailed fit of the T2* decay curve (86). However, this approach is not possible in
this context because this approach is too noisy given the small signal changes induced by
hyperoxia. Higher resolution and thinner slices can also reduce the static field dephasing
effects, but the penalty of reduced signal-to-noise ratio would likely be unacceptable
given the relatively low levels of signal enhancement that can be obtained from BOLD
contrast. Fully refocused fast spin echo approaches to BOLD imaging (87) would be
insensitive to changes in the static magnetic field, but these approaches reduce BOLD
contrast and are often limited by specific absorption rate, especially at high fields.
Furthermore, they may be undesirable in certain hyperoxic contrast studies (e.g. CBV
calculations) since T2-weighted BOLD contrast is dependent on vessel diameter. The T2*
effects due to molecular oxygen in the CSF may be reduced or eliminated by the addition
of saturation, inversion recovery, or long-T2 suppression pulses to the EPI sequence that
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null the signal from spins with long T1 or T2 values. Care must be taken with these
approaches, however, since molecular oxygen reduces the longitudinal relaxation time in
CSF, and T1-weighting of these sequences could result in artifactual increases in signal
intensity if CSF signals are not suppressed adequately.

In conclusion, we have demonstrated that the paramagnetic effects of molecular oxygen
significantly complicate the analysis of BOLD-modulated hyperoxic contrast studies of
the brain. Negative signal changes were observed in T2*-weighted images in the frontal
lobes, and B0 maps suggest this effect is due to increased intravoxel dephasing from
increased static field inhomogeneity from oxygen-induced susceptibility changes in and
around the upper airway. Additional negative signal changes were observed in the
ventricles and brain periphery, suggesting the effect of image distortions from oxygeninduced static field shifts, along with possible increased transverse relaxation rate in the
CSF due to dissolved oxygen. Static field changes during oxygen inhalation were shown
to scale with the main magnetic field strength, and the use of FiO2 = 0.5 was shown to
reduce negative signal changes while maintaining adequate BOLD contrast for accurate
CBV calculation.
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Chapter 3: In Vivo Measurement of Longitudinal Relaxation Time
of Arterial Blood During Hyperoxia

3.1 Overview
ASL measurements of CBF during hyperoxia are confounded by the reduction in
longitudinal relaxation time of arterial blood (T1a) from paramagnetic molecular oxygen
dissolved in blood plasma. The aim of this study is to accurately quantify the effect of
arbitrary hyperoxic levels on T1a. To mitigate artifacts, including the inflow of fresh
spins, partial-voluming, pulsatility, and motion, a pulsed ASL approach was implemented
for in vivo measurements of T1a in the rat brain at 3 Tesla. After accounting for the effect
of deoxyhemoglobin dilution, the relaxivity of oxygen on blood was found to closely
match phantom measurements.

3.2 Introduction
Although it is well-known that inhaled oxygen creates a significant reduction in the T1 of
arterial blood (T1a) (73,88), and that T1a has a substantial effect on CBF measurements
using ASL (89), only a small number of studies using arterial spin labeling (ASL)
approaches to investigate the regional CBF changes during hyperoxia have incorporated
T1a changes in their CBF calculations (37,46). For some of these studies, the T1a changes
during hyperoxia were assumed from results of prior studies of arterial blood at 100%
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oxygen inhalation (46).

Other studies modeled the expected change in T1a during

hyperoxia at intermediate hyperoxia levels, since there are no established values of T1a in
the literature for various oxygen concentration levels (37). These approaches may be
problematic for several reasons. First, the methods used in these studies (73,88) to
measure T1a are prone to several artifacts and errors. These include	
  the	
  inflow	
  of	
  fresh,	
  
un-‐inverted	
   spins	
   from	
   outside	
   the	
   transmit	
   coil,	
   partial-‐voluming,	
   pulsatility,	
   and	
  
motion.	
  	
  Second, even under equivalent conditions of hyperoxia, T1a changes may vary
significantly between individuals due to physiologic variations in the blood. Third, it is
not clear how to effectively model the expected T1a changes at arbitrary oxygen
concentration levels, since T1a may be influenced by various factors other than the
concentration of molecular oxygen in the plasma (e.g., dHb concentration). All of these
issues point to the necessity the measurement of T1a on a per subject and per gas
condition basis that is free from significant artifacts.

To achieve these measurements, we implemented pulsed ASL (PASL) approaches for the
measurement of T1a (90), which allowed for accurate isolation of arterial blood and
minimized partial-‐voluming	
   and	
   pulsatility	
   artifacts. Due to the requirement that the
transmit coil be larger than the subject to avoid the contamination of the measurement
from inflowing spins (90), in addition to the long scan times inherent to inversionrecovery measurements of T1, adult rats were chosen as a model organism, since they are
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substantially smaller than the transmit coil and will experience hematologic changes in
response to hyperoxia that are similar to humans.

3.3 Material and Methods
3.3.1 Phantom Study of Oxygen Longitudinal Relaxivity
To characterize T1 as a function of dissolved oxygen concentration, a phantom study was
performed by bubbling a mixture of nitrogen and oxygen into phosphate-buffered saline
(PBS) in a centrifuge tube held at 370 C in a water bath. After ten minutes, to allow the
gas to fully dissolve in the solution, an airtight lid was secured, and the tube was
immediately transferred to a foam-insulated holder positioned inside the magnet. Since
the measurement of T1 lasted only approximately three minutes, it was not necessary to
heat the phantom while it was in the magnet. An inversion-prepared single-shot FSE
sequence was used with ten inversion times (90, 200, 400, 800, 1200, 1600, 2400, 4000,
6000, 1000 ms) with a TR = 20 s. Temperature measurements were performed before
and after the imaging experiment, and all temperature decreases were found to be less
than 0.50 C. This process was repeated for 0 to 100% oxygen (0 to 760 mm Hg) in steps
of 10%. To investigate the possible influence of blood proteins on the relaxivity of
molecular oxygen, this experiment was repeated with 5% bovine serum albumin in PBS.
All measurements were repeated five times using separate samples.
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3.3.2 Animals
All experiments performed were part of an approved protocol by our Institutional Animal
Care and Use Committee. All data were obtained using adult male Sprague-Dawley rats
(n=5; 434-467 g; Charles River, MA, USA). Anesthesia was induced with 3% isoflurane
in oxygen for approximately five minutes, and the animals were then maintained on
spontaneous inhalation anesthesia consisting of 1.5% isoflurane in 30% oxygen delivered
at 1.5 L/min through a close-fitting nose cone. If the animal showed any signs of
movement during the data acquisition, the anesthesia was increased to 1.7-1.8%
isoflurane for the remainder of the experiment. The fraction of inhaled oxygen (FiO2)
was kept at a minimum of 0.3 instead of 0.21 (air) to ensure that physiologic stability was
maintained and to prevent oxygen desaturation. Normoxia in this context refers to FiO2 =
0.3, and hyperoxia refers to FiO2 = 1. All gases were delivered to the animal with a
manually controlled oxygen and nitrogen flowmeters, which were then mixed, and run
through an inline isoflurane vaporizer.

A temperature-controlled water blanket was

placed under the rat to maintain body temperature at 37.0 ± 0.2 0C; temperatures were
measured continuously with an optical probe inserted in the rectum. Head movement
was restricted during imaging using a custom built MR-compatible animal cradle with
attached earbars. To draw arterial blood gases, an arterial catheter was surgically inserted
using a cut down of the ventral surface of tail. All blood gas samples were measured
using disposable cartridges and a hand-held blood gas analyzer (i-STAT System; Abbott
Laboratories, Abbott Park, IL, USA).

	
  
65	
  

	
  
3.3.3 Hyperoxia Challenge Paradigm
Each rat underwent a series of hyperoxic challenges lasting twenty minutes each. After a
five minute baseline period, gases were manually switched from 30% O2 to 100% O2 for
ten minutes of hyperoxia, and then were switched back to 30% for a five minute baseline.
Data acquired during the first two minutes after switching gases was not analyzed to
allow for physiological adjustment to the new gas condition. Hyperoxic challenges were
repeated continuously without a rest period.

A second imaging experiment was done to determine the degree of T1a change with
hyperoxia. All animals were subjected to graded hyperoxia levels of 40%, 60%, 80%,
and 100% (in order) during continuous measurement of T1a. As before, data acquired
during the first two minutes after switching gases was not analyzed, and there was no rest
period between gas conditions.

3.3.4 MRI Hardware
All imaging experiments were performed using a whole-body clinical 3T MRI scanner
(Siemens Trio; Siemens Healthcare, Erlangen, Germany). RF excitation pulses were
transmitted with the scanner body coil, and MR signals were received with a custom built
single loop (35 mm ID) receive-only head coil passively decoupled during transmit. The
head coil was fixed firmly over the dorsal aspect of the head of the animal.
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3.3.5 Measurement of Arterial Blood T1 (T1a)
A pulsed ASL method based on the work of Thomas, et al. (90) was used to measure T1a
in each animal. A schematic of the pulse sequence is shown in Fig. 3.1. The same
PICORE inversion described above was used to label arterial blood. The inversion was
preceded by an in-plane saturation pulse to limit the interaction of the inversion pulse
with the static tissue spins in the imaging region. The approach used by Thomas, et al.
(90) employed a global saturation pulse to prepare the magnetization along with a flowsensitive alternating inversion recovery (FAIR) ASL sequence.

We used a global

inversion pulse instead of a saturation pulse to prepare the magnetization, which has the
advantage of increased dynamic range. Furthermore, the use of the PICORE ensures that
there is no contamination with venous blood in the measurement, as is possible when
using FAIR. It is important to note that because the transmitter coil is much larger than
the rat, there is no potential for error in the measurement due to the inflow of uninverted
blood into the imaging region. Image acquisition was performed with a single-slice,
single-shot FSE sequence.

Imaging parameters were: TE/TR: 25/8000 ms, slice

thickness = 8 mm, FOV = 64 ×	
  64 mm, matrix size = 64 ×	
  64, and phase encode direction
= left-to-right.
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Figure. 3.1.

Pulse sequence diagram of the PICORE sequence with a global

inversion preparation. An in-plane presaturation pulse was followed by a global
hyperbolic secant inversion pulse. After a variable inversion preparation time, τ, a
second in-plane saturation pulse was followed by either a slab-selective hyperbolic
secant pulse inferior to the imaging slice (tag) or the same pulse without the slabselective gradient (control).
acquisition.

Control and tag pulses were interleaved for each

After an inversion time TI, a single-shot FSE acquisition was

performed. By keeping TI fixed (1.5 s) and using a series of values of τ, a value of
the T1 of arterial blood (T1a) was obtained.

If TI is kept at a constant value while the inversion preparation time τ is varied, the
PICORE signal difference can be expressed as:

[ 3.1 ]

where A is a voxel-specific constant independent of τ.

To allow for a robust,

overdetermined fit to Eq. [3.1] in each animal, ten values of τ (65, 400, 800, 1200, 1600,
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2000, 2400, 3200, 4000, and 6000 ms) were used with a constant TI of 1500 ms. A
randomized acquisition order was used, and tag and control images were interleaved for
each value of τ. Ten repetitions of each value of τ were obtained with a total imaging
time of 27 min.

To increase the number of T1a measurements during hyperoxic

challenges, the same approach was used, except only four values of τ (65, 900, 2500, and
6000 ms) were obtained. To increase the robustness of the fit, these data were only fit for
A and T1a, with the value α taken from the fit from the previous experiment.

3.3.6 Data Analysis
All images were analyzed using routines and scripts written in MATLAB (MathWorks,
Inc.). For analysis of the T1a data, whole brain ROIs were drawn on the PICORE signal
difference images (see Fig. 3.2) and the mean values were determined. The acquisition
using ten values of τ was fit to Eq. [3.1] for α, A, and T1a using a non-linear least squares
fit (MATLAB function, lsqcurvefit). The value of α determined from this fit was used in
the fit of data from the acquisition using four values of τ, so that only A and T1a were fit
to Eq. [3.1]; also, the values from the prior fit were input as starting values for the
subsequent fit. This approach yielded a stable and fast converging fit for all the data.
Before this analysis, the T1a data obtained from all three hyperoxia challenges was
separated into normoxic and hyperoxic periods and averaged. The difference in T1a
between normoxic and hyperoxic states across all animals was compared with a paired
Student’s t-test.
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To analyze the difference in T1a in the blood versus arterial partial pressure of oxygen
(PaO2), the effects of molecular oxygen and deoxyhemoglobin (dHb) were considered.
R1 (1 / T1) is known to increase linearly with increasing dHb concentration (21).
Therefore, the R1 of blood versus PaO2 (longitudinal relaxivity of blood as a function of
PaO2, or r1PaO2) was modeled as the addition of the linear longitudinal relaxivities of
blood as a function of molecular oxygen concentration ([O2]; determined by blood gas
PaO2) and dHb concentration (1-Y, where Y is the fraction of oxyhemoglobin to total
hemoglobin; determined by P50 and blood gas PaO2), which can be expressed simply as:

[ 3.2 ]

The experimental R1a values were fit to this model using a non-linear least squares fit in
MATLAB (function lsqcurvefit).

3.4 Inversion-Prepared ΔM as a Function of Preparation Time
A representative set of ΔM images during normoxia with ten values of τ is shown in Fig.
3.2. As predicted from the model, the signal increased exponentially from an initial
negative value of ΔM and changed globally to the final expected positive value of ΔM as

τ increased. The values of ΔM around the periphery of brain are reduced due the partial
voluming from the large voxel size. However, these effects remain the same across all
values of τ and do not affect the calculation of T1a. The experimental data from the
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whole-brain ROIs from each animal, along with the fits to Eq. [3.1] are shown in Fig. 3.3.
By visual inspection, the magnetization is well described by a monoexponential recovery.
The average value of α was found to be 0.94 in the T1a experiment, which (although still
high) was lower than that found experimentally for a single inversion (0.97).

3.5 Baseline T1a Values and T1a Response to Hyperoxia
The numerical values from the fits of these data are shown in Table 3.1, along with the fit
values obtained from T1a measurements made during the hyperoxic challenges. The
baseline T1a measured with ten values of τ was in very close agreement with the T1a
measured with four values of τ during the baseline normoxic phase measured before,
between, and after the hyperoxic challenges.

The baseline normoxia values of T1a

measured were found to be consistent over time in the same animal, but varied between
animals.

The measured values of T1a during hyperoxia were found to decrease

significantly compared to normoxia (p < 0.01). During hyperoxia, T1a decreased by −89
to −170 ms or −5.6 to −9.4% from normoxia, with an average decrease of −125 ms or
−7.4%. Figure 4 shows the values of T1a calculated for increasing levels of FiO2. Values
of T1a were found to decrease consistently with increasing FiO2, with the relative
decrease in T1a each animal approximately equal.

	
  
71	
  

	
  

Figure. 3.2. A representative set of PICORE signal difference ΔM (control minus
tag) images in arbitrary units (a.u.) from the pulse sequence shown in Fig. 1. Note
that the Δ M signal recovered globally through zero from an initial negative value as
the inversion preparation time τ increased. The mean value from a whole brain
ROI (outlined in white in the control image) was used to analyze the signal behavior.
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Figure. 3.3.

PICORE signal difference (ΔM) in arbitrary units (a.u.) versus

inversion preparation time τ in a whole brain ROI (see Fig. 2) during normoxia
(FiO2=0.3) in five rats. Ten different values of τ were used, and the data was fit to
Eq. [3.1] for each animal using a non-linear least squares regression. The data fits
are shown as solid lines and experimental data are shown as symbols.
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Table 3.1. Measured T1a Values in Whole Brain ROIs During Normoxia (FiO2 =
0.3) and Hyperoxia (FiO2 = 1.0)
Animal no.

Baseline T1a (s)†

Normoxia T1a (s)‡

Hyperoxia T1a (s)‡

1

1.713

1.70

1.54

2

1.651

1.64

1.49

3

1.603

1.58

1.48

4

1.524

1.54

1.45

5

1.609

1.62

1.53

Mean ± SD

1.620 ± 0.069

1.621 ± 0.063

1.496 ± 0.035*

†

Values calculated from measurement performed with 10 inversion preparation times, τ.

‡

Values calculated from measurement performed with 4 inversion preparation times, τ.

*

P < 0.01 from normoxia.

3.6 Longitudinal Relaxivity of Oxygen in PBS and Arterial Blood In Vivo
Figure 3.4a shows R1 versus pO2 in the PBS calibration phantom.

Using a linear

regression, the longitudinal relaxivity of molecular oxygen in PBS was found to be 1.61 ±
0.02 × 10-4 s-1 mm Hg-1, with R2 = 0.99. No statistically significant difference was found
in the relaxivity of the phantom containing bovine serum albumin.

Fig. 3.4b shows R1 versus PaO2. The PaO2 was measured for each case using arterial
blood gas. Using the fit to the model shown in Eq. [3.2] above, the r1[O2] was determined
to be 1.59 ± 0.21 × 10-4 s-1 mm Hg-1, while the r1[dHb] was found to be 0.246 ± 0.051 s-1
(1-Y)-1. There was found to be a clear influence of dHb on T1a values measured between
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FiO2 = 0.3 and 0.6, with the T1a at FiO2 = 0.4 actually showing a slight increase. At
higher FiO2 levels, the longitudinal relaxivity with PaO2 appeared to be linear. The
values of T1a were found to be 1.632 ± 0.037 ms, 1.641 ± 0.035 ms, 1.606 ± 0.033 ms,
1.549 ± 0.024 ms, and 1.514 ± 0.027 ms for FiO2 = 0.3, 0.4, 0.6, 0.8, and 1.0,
respectively. There was no statistically significant difference between the T1a measured
during FiO2 = 1.0 during the first experiment (rapidly alternating oxygen levels) and the
second experiment (gradual hyperoxia).

	
  
75	
  

	
  

Figure 3.4. Effect of oxygen concentration on R1 in a phosphate-buffered saline
(PBS) phantom (a) and effect of arterial oxygen tension on R1 of arterial blood (b).
The marker indicates the experimental data, and the lines indicate the fits to the
data. The effect of oxygen on R1 in (a) was shown to be well-described by a linear fit
to the data. The data were well described by a model incorporating the linear
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relaxivity effect of both molecular oxygen and deoxyhemoglobin. Values shown are
mean ± SD.

3.7 Chapter Discussion
In this study, we have measured T1a in vivo at 3T during normoxia and hyperoxia using a
novel PASL approach. This particular approach is notable for avoiding several artifacts
and the requirement for physiological gating. Compared to a similar approach in the
literature, it approximately doubled the dynamic range with the use of an inversion
preparation, avoided possible venous signal contamination with a PICORE inversion, and
maximized the signal-to-noise ratio (SNR) in the presence of static field inhomogeneities
by using a FSE readout. We have accurately measured the longitudinal relaxivity of
oxygen at physiologic temperature at 3T. Additionally, our model of the relaxivity of
arterial blood accurately describes the situation in vivo by incorporating the effect of the
longitudinal relaxivity deoxyhemoglobin. Given that the longitudinal relaxivity was not
effected by albumin, it is likely that the interaction of molecular oxygen with blood
proteins is too rapid to affect T1a. Therefore, the measured relaxivity of oxygen in blood
is likely to be independent of B0, and these relaxivity values can be used for experiments
at different field strengths.

The average value of T1a measured during normoxia shows close agreement to values
from previous studies in vivo (1623 ms; (91)) and in vitro (1664 ms; (92)). The measured
value of T1a in response to oxygen was shown to closely agree with phantom data after
	
  
77	
  

	
  
accounting for the effect of changing dHb concentration on T1a. The measured relaxivity
of dHb was found to be in agreement with previous results (21,92). Additionally, the
reduction in T1a due to oxygen was observed to be rapid and consistent across large
differences in the duration of oxygen exposure. The observed T1a changes of our in vivo
data very closely approximated the more robust phantom data.

Although not a trivial operation, the measurements of T1a in rat blood made in this study
can be translated to human studies. Given the similarity in the constitution of blood
between the two species, the longitudinal relaxivity from dissolved molecular oxygen is
likely to be very similar. The most important difference between species is effect of
deoxyhemoglobin, which will exist in different concentrations at the same PaO2 (due to
the difference in P50) and will likely exhibit different longitudinal relaxivity. However, if
these effects can be characterized and accounted for, it should be possible to accurately
estimate the change in T1a during any oxygen challenge, given knowledge of PaO2 during
normoxia and hyperoxia. To this end, it is possible to estimate PaO2 from end-tidal
oxygen concentration, given normal lung physiology (6).

In conclusion, using measurements of in phantoms and in vivo arterial blood, we have
demonstrated that T1a is well described by the linear combination of longitudinal
relaxivities of molecular oxygen and deoxyhemoglobin. By comparing brief and graded
hyperoxic inhalation paradigms, we have shown that T1a changes rapidly and remains
stable with changing FiO2.
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3.8 Future Directions
Given the challenges of making in vivo T1a measurements in humans, the use of small
animal model may be the most practical method for T1a calibration for human
experiments. However, a direct measurement of T1a on a per subject and per condition
basis is still a desirable goal, given the relatively large inter- and intrasubject variability
in T1a in baseline normoxia as well as in response to oxygen challenge. Although such an
approach may be feasible, we found a consistent underestimation of T1a by several
hundred milliseconds when applying the above method to humans using the same clinical
scanner. Several changes from the present approach are likely to be necessary to obtain
this goal, including minimizing the number of acquired inversion preparation times, and
the application of the constraint on the duration of the inversion preparation times to
values short enough to avoid contamination of spins flowing in from outside the transmit
coil.
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Chapter 4: Absolute Quantification of Cerebral Perfusion with Pulsed Arterial
Spin Labeling During Hyperoxia

4.1 Overview
As discussed in Chapter 1, quantitative arterial spin labeling estimates of cerebral
perfusion during oxygen inhalation are important in several contexts, including
functional experiments calibrated with hyperoxia and studies investigating the effect of
hyperoxia on regional perfusion. The aim of this study is to accurately quantify the effect
of arbitrary levels of hyperoxia on CBF on a per-subject basis using ASL by correcting
for T1a with a simultaneous measurements on a per subject, per gas condition basis. The
results of this study suggest that measured ASL signal changes are dominated by
reductions in T1a for brief hyperoxic inhalation epochs, while physiologic effects of
oxygen on vasculature account for most of the measured reduction in CBF for longer
hyperoxic exposures.

4.2 Introduction
Hyperoxic gas inhalation, through increases in the arterial partial pressure of oxygen and
hemoglobin saturation (SaO2), exerts significant effects on the vasculature and is not
physiologically inert. Many studies have shown that oxygen reduces cerebral blood flow
(CBF) due to at least one independent vasoconstrictive mechanism, including the
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attenuation of the effect of nitric oxide, an endogenous vasodilator (5,49,50,93). While
the vasoconstrictive effect of oxygen is well known, the degree to which CBF changes
occur during hyperoxia remains the subject of ongoing research. Moreover, if inhaled
oxygen is to be used as a quantitative contrast agent, precise characterization of its
changes to the underlying physiology is crucial.

Several studies have used arterial spin labeling approaches to investigate the regional
CBF changes during hyperoxia (5,37,46,48,93,94), but only a small number of these
studies have incorporated T1a changes in their CBF calculations (37,46). As mentioned in
Chapter 3, the reduction of T1a will significantly affect measured values of CBF using
ASL, as preparation times of ASL inversion pulses are on the order of the T1 of the
tagged spins (89). In this study, our aim was to simultaneously measure CBF and T1a in
vivo during various levels of hyperoxia using the method outlined in Chapter 3. In
particular, we wanted to explore the previously reported finding (37,46) that CBF change
as measured by ASL during hyperoxia is primarily artifactual, since it is dominated by a
reduction in T1a (37,46). We implemented a pulsed ASL (PASL) approach for CBF that
was similar in implementation to the arterial spin tagging method outlined in Chapter 3.
Using this method, we were able to simultaneously measure these parameters in the brain
without moving the subject. As discussed in Chapter 3, although there is no reason in
theory that these measurements cannot be done in vivo in humans, technical issues
require that a smaller experimental animal be used. The rat was chosen due to its
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physiologic stability under anesthesia and the relative similarity of its physiologic blood
responses to humans.

4.3 Material and Methods
4.3.1 Animals
All experiments performed were part of an approved protocol by our Institutional Animal
Care and Use Committee. All data were obtained on adult male Sprague-Dawley rats
(n=13; 429-472 g; Charles River, MA, USA).

Inhalation anesthesia was induced and

maintained in the same manner as described in Section 3.3.2. All arterial blood gases
were drawn from tail artery catheter. Again, to ensure that physiologic stability was
maintained and to prevent oxygen desaturation, animals were maintained with a
minimum FiO2 of 0.3 (normoxia in this study).

Gases were delivered and altered,

temperature was maintained constant, and head movement was restricted as described in
above in Chapter 3.

4.3.2 Hyperoxia Challenge Paradigms
The response of CBF to oxygen was studied under two different hyperoxia paradigms:
(1) a brief hyperoxic challenge (Group I) and (2) an increasing, graded hyperoxic
challenge (Group II), as illustrated in Fig. 4.1. All data acquired during the first two
minutes after switching gases were not analyzed to allow for physiological adjustment to
the new gas condition. To investigate possible effects unrelated to variations in inspired
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oxygen (e.g. scanner drift, duration of anesthesia, etc.), data were collected for control
animals (n=2) using the same measurement protocols of Group I and II described below
without switching gas conditions (i.e., under continuous normoxia).

In Group I (n=7), each rat underwent a baseline – stimulation – rest paradigm. After a
five minute baseline period, gases were switched from 30% O2 to 100% O2 for ten
minutes of hyperoxia, and then were switched back to 30% for a five minute baseline.
This paradigm was repeated three times during continuous measurement of T1a and CBF
(detailed below). In addition, a second experiment was performed in Group I animals to
determine the degree of T1a change with hyperoxia.

Animals underwent graded

hyperoxic inhalation epochs of 40%, 60%, 80%, and 100% (in increasing order) lasting
approximately ten minutes each during which continuous measurements of T1a were
made.

In Group II (n=6), both T1a and CBF were measured with graded hyperoxic inhalation
epochs of 30%, 40%, 60%, 80%, and 100% (in increasing order). Each measurement of
T1a or CBF lasted approximately ten minutes, with two measurements of CBF occurring
between two measurements of T1a to minimize temporal effects.

After gases were

switched, approximately ten minutes elapsed before the start of the measurements to
allow for physiological equilibration to the new gas condition.
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For Group II, arterial blood gases were drawn from a subset of animals (n=4) during the
imaging experiment immediately after each inhalation epoch. For Group I, blood gases
were also analyzed from a subset of animals (n=4), but samples were drawn on a
subsequent day to eliminate possible effects of the blood draw on the imaging experiment
(95). Arterial blood gas measurements were not considered to be a significant issue for
Group II animals, as there was adequate recovery time after each blood withdrawal (8-9
min). All blood gas samples were measured using the technique described previously
(Section 3.3.2).

Figure 4.1.

Hyperoxic challenge paradigms used for Group I and II animals.

Group I animals underwent a baseline – stimulation – rest paradigm (5 – 10 – 5
min) to assess the effects of a brief hyperoxic inhalation challenge on CBF and T1a.
Group II animals experienced a graded hyperoxic challenge to test the effects of
longer oxygen exposures on CBF and T1a.

Each gas inhalation period lasted

approximately 40 minutes. To minimize temporal effects, two CBF measurements
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were placed between two T1a measurements. In addition, in Group I animals, a
graded hyperoxic inhalation was used to assess T1a at different oxygen
concentrations.

4.3.3 Measurement of Cerebral Blood Flow (CBF) with Pulsed ASL
All imaging experiments were performed using the same MRI scanner and custom RF
hardware as described in Section 3.3.4. The measurement of arterial blood T1 was
performed in the same manner as described previously. Briefly, a dataset was collected
initially with ten inversion preparation times (τ) to allow for a robust fit to Eq. 3.1 to
determine T1a and α.

When hyperoxic gas changes were implemented, a shorter

approach was used with four values of τ to increase signal-to-noise of the T1a
measurement. Data from these shorter acquisitions were only fit to A and T1a of Eq. 3.1.

To quantify CBF, a pulsed ASL technique developed by Wong and Luh (96,97), was
used in this study for regional quantification of CBF (shown in Fig. 4.2). This technique
involves quantitative imaging of perfusion using a single subtraction with thin-slice TI1
periodic saturation (Q2TIPS) based on proximal inversion with control for off-resonance
(PICORE) tagging. This method is insensitive to spatially varying transit delay (δt) and
flow-through effects (98), which have been shown to be significant sources of systematic
error in perfusion quantification in rats (99).

	
  
85	
  

	
  

A multi-shot fast spin echo sequence (FSE) was used for data acquisition. This approach
is insensitive to static field inhomogeneities, and therefore should be insensitive to the
hyperoxia-induced B0 shifts discussed in Chapter 2. The inversion pulse for tagging
consisted of a 40 ms adiabatic hyperbolic secant pulse with a 100 mm slab thickness
(gradient turned off for the control image) positioned 10 mm proximal to the inferior
imaging slice. To saturate the tag, a series of 900 three-lobe sinc pulses with 20 mm slab
thickness, positioned 10 mm proximal to the inferior imaging slice were used for periodic
saturation. The inferior saturation pulses were 20 mm thick and spaced 25 ms apart,
creating a cutoff velocity of 80 cm/s (97). This cutoff velocity was considered sufficient
to saturate inflowing spins because peak systolic velocity in normal rat carotid arteries
measured with ultrasound is typically found to be less than 60 cm/s (100). Periodic
saturation was continued until image acquisition to ensure full saturation of intravascular
spins during imaging. The imaging parameters were: TI1 = 900 ms, TI1S = 1475 ms, TI2
= 1500 ms, TE/TR = 6/4000 ms, slice thickness = 2 mm, slice gap = 2 mm, no. of slices =
3, FOV = 40 ×	
  40 mm, matrix size = 64 ×	
  64, no. of segments = 5, phase partial Fourier
factor = 5/8, echo spacing = 6.03 ms, and time between slice acquisitions = 54 ms. The
phase encode direction was set left-to-right to avoid pulsation artifacts from the carotid
arteries beneath the brain. ASL tag/control pairs were obtained in 40 s (TR = 4 s ×	
   5
segments × 2). The equilibrium magnetization scan was acquired with the exact same
imaging parameters, except there were no saturation or inversion pulses, and TR was set
to 15 s.
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Figure 4.2. A multi-shot fast spin echo sequence (FSE) quantitative imaging of
perfusion using a single subtraction with thin-slice TI1 periodic saturation (Q2TIPS)
based on proximal inversion with control for off-resonance (PICORE) tagging. By
saturating the end of the tag using a series of 900 three-lobe sinc pulses, this method
is insensitive to spatially varying transit delay (δ t) and flow-through effects

The ASL signal difference ΔM is independent of δt (96) and the signal can be expressed
by:

[ 4.1 ]

[ 4.2 ]
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where α is inversion efficiency (=1 for perfect inversion), M0a is the fully relaxed
longitudinal magnetization of arterial blood, f is cerebral blood flow in ml blood/g
tissue/min, T1a is the longitudinal relaxation time of arterial blood, and σ is the time
duration of tag. Since the inversion pulse covered the entire rat heart and lungs, the tag
did not have an end; typical values of δt for vessels of the rat neck to the brain are less
than 400 ms (99). Therefore, the parameters used here should meet the conditions of Eq.
[4.2] for all imaging regions. Using an agarose phantom, the inversion efficiency was
determined experimentally to be approximately 0.97.

Although changing oxygen

concentrations along the vascular tree and spin exchange with different tissue
compartments make the use of a single value T1a a somewhat oversimplified approach
(101), the model in Eq. [4.1] is a reasonable approximation since the tagged spins will
spend the majority of TI in the arteries and arterioles.

Furthermore, this model is

important to consider since it represents the maximum degree of change in measured
CBF that could be expected from a change in T1a (see Chapter Discussion).

The value of magnetization of arterial blood was estimated on a per voxel basis using the
local transverse magnetization of the reference scan and scaling it to the blood-brain
partition coefficient (89,102). This method of estimating local M0a has the advantage of
simultaneously correcting for inhomogeneities of the receive coil (103). Correcting for
the proton density and the relaxation rate of the local transverse magnetization and
arterial blood, the magnetization of arterial blood can be expressed as:
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[ 4.3 ]

where R is the signal ratio of local transverse magnetization to blood in a proton-density
weighted image, M0 is the voxel signal intensity, T2LT is the T2 of the local transverse
magnetization, and T2a is the T2 of arterial blood. An approximate value of R=0.98 was
taken from human studies (104). The T2 of human gray matter at 3T (80 ms; (105)) was
used to estimate a value of T2LT, and an approximate value of T2a (100 ms) was
determined from the literature (22).

Because of the minimal T2-weighting of our

sequence (TE = 6 ms), the expected oxygenation changes occurring at the arteriole and
capillary spaces during hyperoxia are expected to yield changes in T2a that would change
the measured signal by less than 1% (22,73,88). Therefore, we assumed a single estimate
of T2a for normoxic and hyperoxic states.

T2-weighted anatomical images were acquired with a multi-shot FSE sequence with the
same slice prescription as the ASL sequence, with the following parameters: TE/TR:
81/4000 ms, slice thickness = 2 mm, slice gap = 2 mm, no. of slices = 3, FOV = 40 ×	
   40
mm, matrix size = 192 ×	
  192, no. of segments = 24, and no. of averages=6.
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4.3.4 Data Analysis
All images were analyzed using routines and scripts written in MATLAB (MathWorks,
Inc.). Analysis of the T1a data was performed in the same manner as previously described
in Section 3.3.6. Before this analysis, the T1a data for each animal and gas condition in
Group I and Group II were compiled. For Group I T1a data, the difference in T1a between
normoxic and hyperoxic states across all animals was compared with a paired Student’s ttest. A one-way analysis of variance (ANOVA) was used to compare the difference in
T1a values between different gas conditions pooled from Groups I and II.

CBF maps were generated for each gas condition for all animals in Group I and II using
the T1a measured during normoxia (T1a uncorrected), and another CBF map was
generated for the hyperoxic condition using the value of T1a measured in that animal for
the given level of hyperoxia (T1a corrected). CBF data were analyzed regionally for
normoxia and hyperoxia (FiO2 = 0.3 and 1.0) and whole brain averages for all gas
conditions in both experimental groups.

Regional analysis was performed because

several studies have suggested that there are significant regional variations in the
reduction of CBF during hyperoxia (37,46,49). Using the anatomical images, regions-ofinterest (ROIs) were manually drawn using a standard rat brain atlas (106) and were then
transferred to the perfusion maps. The differences across all ROIs between the two gas
conditions were measured using a two-way ANOVA with replication. If the ANOVA
showed significant differences in the means between the two gas conditions across all
ROIs, analysis of the source of the differences using paired Student’s t-test between
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individual ROIs was considered to be warranted. In all cases, a value of p < 0.05 was
considered a statistically significant difference.

4.4 Arterial Blood Gas and Blood Pressure Analysis
The arterial blood gas parameters from Group I and Group II are shown in Tables 4.1 and
4.2, respectively. Data in Group I show a statistically significant increase in PaO2 (402.3
mm Hg), producing a 7% increase in SaO2. Data from Group II were in close agreement
with Group I, showing a very similar increase in PaO2 (401.9 mm Hg), with increase in
PaO2 in the intermediate steps closely approximating the relative change in FiO2. A mild
but significant increase in the arterial partial pressure of carbon dioxide (PaCO2) was
measured from FiO2 = 0.3 to 1.0 in Group I (2.3 mm Hg) and Group II (3.2 mm Hg).
Mean arterial blood pressure (MABP) (measured in Group I only) and pH were not found
to change significantly.

Table 4.1. Arterial Blood Gas Parameters for Normoxia and Hyperoxia in 1.5%
Isoflurane Anesthesia (Group I)
FiO2

pH

PaCO2
(mm Hg)

PaO2
(mm Hg)

SaO2 (%)

MABP (mm Hg)

0.3

7.44 ± 0.03

45.3 ± 1.8

97.0 ± 8.3

92.9 ± 1.3

73.5 ± 4.9

1.0

7.43 ± 0.04

47.6 ± 1.6*

499.3 ± 32.2*

99.9 ± 0.1*

73.9 ± 5.3

*

P < 0.05 from normoxia.
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Table 4.2 Arterial Blood Gas Parameters for Graded Levels of Hyperoxia in 1.5%
Isoflurane Anesthesia (Group II)
FiO2

pH

PaCO2
(mm Hg)

PaO2
(mm Hg)

SaO2 (%)

0.3

7.45 ± 0.03

44.7 ± 1.2

99.3 ± 11.6

93.0 ± 2.1

0.4

7.44 ± 0.03

45.3 ± 1.0

154.3 ± 13.6

97.7 ± 0.6

0.6

7.44 ± 0.02

46.1 ± 0.8

266.8 ± 16.8

99.4 ± 0.1

0.8

7.44 ± 0.01

46.7 ± 0.6

388.8 ± 13.4

99.8 ± 0.0

1.0

7.43 ± 0.02

47.9 ± 0.8

501.2 ± 23.0

99.9 ± 0.0

4.5 Cerebral Blood Flow Mapping with Correction for T1a
An anatomic dataset from a representative animal from Group I is shown in Fig. 4.3,
along with outlines of ROIs used in the analysis of the perfusion maps. Quantitative CBF
maps during normoxia and hyperoxia are shown below. A reduction in calculated CBF
values in several regions across the brain can be clearly visualized. Correcting for T1a
measured during hyperoxia clearly reduced the degree of the differences between
normoxia and hyperoxia, but reduced CBF values can still be visualized. To demonstrate
the degree of CBF reduction due to hyperoxia in our experimental setup, Fig. 4.4 shows
the time course of average ΔM across all the ROIs during the hyperoxic challenges for a
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representative animal. The signal intensity of the control image was modulated by the
BOLD signal; although the signal change was small due to the short TE, it clearly shows
the effects of inhaled oxygen across the experiment. Overlays of the measured reduction
(in percent decrease) on anatomical images of the CBF maps corrected for T1a from
Group II are shown in Fig. 4.5a. The observed CBF reduction seems to be somewhat
regional in nature, with a larger effect in the cortex compared to other regions. The effect
of FiO2 on whole brain CBF measured from Group II animals is shown in Fig. 4.5b. CBF
shows a consistently decreasing trend with time and increasing FiO2.
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Figure 4.3. T2-weighted structural images with ROIs (outlined in white) for analysis
of regional CBF values (corresponding columns below), from a representative
animal. ROI values from both hemispheres were averaged. In the left column, the
inferior slice (bregma -6.5 mm) contains (1) visual/auditory cortex and (2)
hippocampus/subiculum. In the middle column, the middle slice (bregma -2.5 mm)
contains (3) sensory/auditory cortex, (4) hippocampus, and (5) thalamus. In the
right column, the superior slice (bregma 1.5 mm) contains (6) motor/sensory cortex
and (7) caudate putamen. CBF values (in ml/100 g/min) in the second row were
calculated during normoxia (FiO2 = 0.3) from Eq. [1] using T1a value measured
during normoxia, while CBF values in the in third and fourth row were calculated
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during hyperoxia (FiO2 = 1.0) using the T1a measured during normoxia
(uncorrected) and hyperoxia (corrected).

Figure 4.4. Representative signal time course of Δ M (control minus tag) and control
image signal intensity during normoxia (FiO2 = 0.3; white regions) and hyperoxia
(FiO2 = 1.0; green regions). Signal values were calculated at each time point from
the mean of all ROIs (see Fig. 4). Units were calculated as the percent difference
from starting baseline. Control image signal intensity is increased during hyperoxia
due to BOLD response; percent signal change is low (~0.5%) due to the degree of
T2-weighting (TE = 6 ms).
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Figure 4.5. Overlays of the measured reduction (% decrease) on anatomical images
of the CBF maps from a representative animal (a) and the effect of FiO2 on wholebrain relative CBF. Both sets of data come from Group II animals. The data shown
(a) have been corrected for the per subject change in T1a; the observed CBF
reductions appears to be regional in nature, with the largest effects observed in the
cortex. Relative CBF in (b) shows a consistently decreasing trend with time and
increasing FiO2.

The squares and circles represent the data uncorrected and

corrected for the change in T1a, respectively. Values are mean ± SD.
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4.6 ROI Analysis of Hyperoxia-Induced CBF Reduction
ROI analysis of mean calculated CBF across animals for normoxia and hyperoxia (FiO2 =
1.0) in Groups I and II is shown in Figs. 4.6a and b, respectively. CBF was significantly
reduced across all ROIs before and after correction for T1a in both Groups I and II, as
determined by ANOVA. CBF decreases were larger in the Group II animals, with all
regions still showing statistically significant reductions in CBF after correction for T1a.
There appeared to be some regional nature to the CBF reduction, particularly in Group II
animals where, after correction for T1a, the sensory/auditory cortex region showed a
23.5% reduction, while the caudate putamen region only showed a 10.9% reduction.
After T1a correction, whole brain values of CBF exhibited a normoxia to hyperoxia
reduction of 109.2 ± 12.9 ml/100 g/min to 103.9 ± 10.4 ml/100 g/min in Group I and
108.3 ± 11.0 ml/100 g/min to 90.2 ± 12.5 ml/100 g/min in Group II. The correction for
the change in T1a dominated the Group I correction, accounting for 63% of the increase in
the observed reduction in CBF. In Group II, the T1a change contributed significantly less,
accounting for 28% of the increase in the observed reduction in CBF.
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Figure 4.6. Mean calculated CBF values (ml/100 g/min) in seven ROIs (both
hemispheres; see Fig. 4.3) during normoxia (FiO2 = 0.3; dark gray bars) and

	
  
98	
  

	
  
hyperoxia (FiO2 = 1.0) uncorrected (light gray bars) and corrected (white bars) for
T1a during hyperoxia. Data are were taken from Group I (a) and Group II (b).
Values are mean ± SD. * P < 0.05 from normoxia.

4.7 Chapter Discussion
In this study, T1a and quantitative CBF were measured in vivo at 3T during normoxia and
hyperoxia using PASL approaches. The measured T1a values were used to correct the
calculated CBF in each experimental animal under a brief hyperoxic inhalation and
graded hyperoxic inhalation paradigms. As discussed in Chapter 3, the reduction in T1a
due to oxygen is rapid and consistent across large differences in the duration of oxygen
exposure.

The changes in CBF, however, were found to be significantly different

depending on the oxygen exposure duration. The longer exposures of the slow, graded
hyperoxic inhalation paradigm of Group II produced significantly more reduction in
CBF. This is in agreement with established effects of hyperoxia on cerebral blood flow,
as the attenuation of effects of nitric oxide effects have been shown to depend on the
duration of hyperoxic exposure (50). Overall, the results of this study suggest that the
observed reduction in CBF measured by ASL is dominated by T1a reduction during short
term inhalation epochs, but physiologic effects become the primary source of the
reduction over longer hyperoxic exposures.
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Although the measured longitudinal relaxivity of T1a as function of PaO2, and therefore
the CBF correction, determined in this study were found to be significantly smaller than
those used in previous studies (37,46), we have grounds to be confident in the findings of
our study. As discussed in Chapter 3, we found that the observed T1a changes of our in
vivo data very closely approximated the more robust phantom data.

Perhaps more

significantly, the correction made in this study most likely represents the maximum
degree to which the reduction in T1a would decrease the measured CBF reduction. We
have assumed that spins measured in the ASL experiment have spent the vast majority of
TI (inversion time) in a compartment that approximates arterial blood. However, toward
the end of TI, a significant portion of tagged spins will enter the capillary and tissue
spaces. In these regions, the change in pO2 during hyperoxia will be substantially lower
(47), yielding a smaller change in T1. In addition, in the capillary space, the mild dilution
of deoxyhemoglobin is likely to yield a slight increase in T1. In order to accurately
account for these effects, it will be necessary to develop a model of the average change in
pO2 experienced by the tagged spins over the duration of TI. Such a model would need
to incorporate the temporal characteristics of inflowing blood water and describe the
relative amount of spins in each tissue compartment as a function of time. For these
reasons, the ASL signal model used in this study is not complete, and the effective
reduction in the T1 experienced by the tagged spins is likely to be significantly less than
the measured reduction in T1 of arterial blood. However, the use of this model is
important, since it represents the upper bound to which the reduction in CBF measured
can be attributed to a reduction in T1 of the spins measured by the ASL experiment.
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Baseline mean values of CBF across the rat brain during normoxia were in close
agreement to literature values (93,94). In agreement with previous studies in humans and
mechanically ventilated animals (37,46,48,93), a reduction in regional CBF with
hyperoxia was observed. The response to brief inhalation epoch was more uniformly
global and appeared to demonstrate less regional variance compared to the longer
hyperoxic exposure of the graded inhalation.

As mentioned above, this may have

physiologic foundation, since T1a changes produce only a global effect, but it remains
unclear whether local physiologic effects, like nitric oxide attenuation, exhibit variations
that are more regional in nature. Contrary to the results of a previous study of hyperoxia
in free-breathing rats that showed a mild increase in CBF (5), we found that CBF
consistently decreased with hyperoxia. The presumed source of the increase in CBF in
the previous study was mild hypercapnia caused by hyperoxia-induced hypoventilation,
and we also observed a slight increase in pCO2 during hyperoxia. However, very short
hyperoxic epochs (~2 min) were used in the previous study (5), which are likely too short
to observe the vasoconstrictive effects of hyperoxia (37,48,93). Furthermore, the levels
of isoflurane used in the present study were significantly higher (1.15-1.25% versus 1.51.8%), and isoflurane is known to substantially suppress the effects of CO2 on the
vasculature (94). We believe these factors explain why the effects of elevated pO2 on
CBF were dominant in the present study. However, the elevation in pCO2 is a likely
confounding factor in this experiment, and if normocapnia was maintained, it is likely
that a larger reduction in CBF would have been observed.
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In conclusion, simultaneous in vivo measurements of T1a and CBF were performed using
PASL approaches during normoxia and hyperoxia in rat brains at 3T under a brief
hyperoxic inhalation and graded hyperoxic inhalation paradigms. The results of this
study suggest that the measured reduction in CBF using ASL is dominated by T1a
reduction during short term inhalation epochs, but physiologic effects become the
primary source of the ASL signal reduction for longer hyperoxic exposures.
Furthermore, the inter- and intrasubject variability during normoxia and in response to
hyperoxia observed in this study underscores the importance of the accurate measurement
of T1a in quantitative ASL studies.
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Chapter 5: Hyperoxic Calibrated Quantitative fMRI for the
Measurement of Regional Cerebral Metabolic Rate of Oxygen
in a Hypermetabolic Swine Model

5.1 Overview
The aim of this study is to quantify relative metabolic changes using hyperoxic calibrated
BOLD/ASL fMRI in a hypermetabolic swine model. Metabolic changes using this large
animal model were previously studied by our group using gas that is isotopicallyenriched with 17O2. We sought to cross-validate these measurements with hyperoxic dHb
dilution methods of relative metabolism and to compare the results of hyperoxia and
hypercapnia calibration methods using this animal model.

5.2 Introduction
Significant progress has been made in developing quantitative approaches to measure
relative changes in metabolism in normal brain tissue with MRI, using calibrations of
simultaneous BOLD and ASL data with inspired gases (6),(107). Although these studies
generally show agreement in producing the same relative changes in CMRO2 under
similar stimuli as compared with quantitative measurements such as PET (107), there
have been no studies cross-validating these MRI techniques with simultaneous absolute
measurements of metabolism. Part of the reason these studies have not been performed
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is the extreme technical difficultly in performing these experiments, as dual-mode
PET/MRI scanners have only recently come into existence (108). However, a method
measuring absolute metabolic rates using MRI would allow for these simultaneous crossvalidation studies to be performed much more easily.

To date, the only MRI methods capable of measuring absolute metabolic rates are those
using the inhalation of gas isotopically-enriched with 17O2 (109). These methods work by
detecting the increase in the transverse relaxation rate created by (i) exchange modulation
of J-coupling between

17

O and 1H in H217O formed by the metabolism of

17

O2

immediately after its inhalation and (ii) exchange of 1H between this newly formed H217O
with H216O (3). While extensive studies of

17

O2 inhalation have been performed in

animal models, human experiments have been limited to small studies by a few groups.
This fact is due primarily to regulatory issues, but it is also because of the expense and
technical difficulty of the experiment, including the need for rapid delivery and recovery
of the exhaled 17O2 gas (3).

Our group has recently developed an approach that is capable of performing
inhalation experiments in humans using an apparatus to deliver brief

17

17

O2

O2 pulses (110).

We tested it with a large animal model of elevated metabolism using 2,4-dinitrophenol
(3). This hypermetabolic model in swine was devised to generate a stable metabolic
increase across the entire brain by at least a factor of two. By comparison, stimulation of
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brain metabolism by other methods such as peripheral motor stimulation are transient,
highly localized, and generally increase metabolism by less than 30% (5). In this model,
hypermetabolism is induced by administering 2,4-dinitrophenol (DNP), which disrupts
the mitochondrial proton gradient that is used by ATP synthase to generate ATP (111).
This disruption causes the cell to respond by using additional energy resources to reestablish a normal proton gradient. This additional energy expenditure dramatically
increases total metabolism and oxygen consumption. Using these approaches, our group
has measured substantial whole brain CMRO2 increases of approximately 17% per mg/kg
DNP in this animal model (3).

In this study, we set out to determine the feasibility of measuring the change in CMRO2
in this hypermetabolic swine model using simultaneous BOLD and ASL acquisitions
calibrated with isometabolic dHb dilution using hyperoxia (6) and hypercapnia (107).
The goal of this study was twofold: (1) to cross-validate the results of the change in
CMRO2 with the prior study using 17O2 and (2) to compare the results of hyperoxic and
hypercapnic calibration methods. To this end, we carried out the experiment in the same
manner as the prior

17

O2 inhalation study and performed an analysis of CMRO2 at the

same time point after administration of the same dose of DNP.
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5.3 Materials and Methods
5.3.1 Animal Preparation
All experiments performed were part of an approved protocol by our Institutional Animal
Care and Use Committee. Juvenile Yorkshire pigs (n=8; 23-30 kg) were anesthetized
with an intramuscular injection of ketamine (25 mg/kg), medetomadine (0.1 mg/kg), and
glycopyrrolate (0.02 mg/kg). Anesthesia was maintained with a continuous IV infusion
of ketamine (20-80 mg/kg/hr) and was increased incrementally if the animal exhibited
motion or response to stimuli.

Animals were mechanically ventilated through an

endotracheal tube using a custom-built precision delivery breathing circuit (110).
Diazepam (0.02-0.08 mg/kg) was delivered by IV infusion as needed to reduce any
ventilation resistance. Ventilator settings were set at a respiratory rate (RR) of 8-12
breaths per minute with a tidal volume of 20-25 mL/kg and were constantly monitored
and adjusted to keep oxygen saturation by pulse oximetry (SpO2) and end-tidal CO2 at
normal levels (>98% and <40 mm Hg, respectively).

After the experiment was

completed, all animals were euthanized with pentobarbital administered under anesthesia.
Normal temperature (38 ± 10C) was maintained throughout the experiment with a water
warming blanket. To draw arterial blood gases, an arterial catheter was inserted in the
medial aspect of the hind limb using ultrasound guidance in the large animal fluoroscopy
suite. All blood gas samples were measured using disposable cartridges and a hand-held
blood gas analyzer (i-STAT System; Abbott Laboratories, Abbott Park, IL, USA).
Arterial oxygen saturation and heart rate were constantly monitored throughout the
experiment with a veterinary pulse oximeter (Nonin 8600V, Nonin Medical, Inc.,
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Plymouth, MN, USA) attached to the ear. End-tidal CO2 (EtCO2) was continuously
monitored with a capnograph (Capnostream 20, Oridion Capnography Inc., Needham,
MA), which was sampled using a port at the expiratory side of the ventilator close to the
mouth.

5.3.2 Preparation and Administration of 2,4-Dinitrophenol
DNP solutions were prepared in the same manner as our group’s prior

17

O inhalation

studies (109). Briefly, the DNP solution prepared within 1 day of use by combining 2.5
mg/mL of DNP (Sigma-Aldrich D198501) and 5 mg/mL of sodium bicarbonate to 0.9%
saline. The solution was brought to approximately 700C with constant stirring to dissolve
all solutes. The solution was then allowed to cool to room temperature and filtered
through a 0.1 µm vacuum filter (Millipore SCVPU02RE).

After all gas calibrations (described below) were performed, 9 mg/kg of DNP were
administered to the animal by slow IV infusion as described previously (109). Animals
were monitored for approximately sixty minutes before euthanasia. Two pigs became
very physiologically unstable after DNP injection, so their datasets were removed from
the final analysis.
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5.3.3 Hyperoxia and Hypercapnia Challenge Paradigms
The swine were given a single, ten minute hyperoxia (FiO2 = 1.0) and hypercapnia (6%
CO2 in air) challenge in a baseline – stimulation – rest paradigm (5 min baseline, 10 min
stimulation, 10 min rest). Data acquired during the first five minutes were discarded to
allow time for physiologic adjustments to the new gas condition. At the very end of the
gas challenge, an arterial blood gas sample was drawn.

5.3.4 MRI Hardware
All imaging experiments were performed using a whole-body clinical 1.5T MRI scanner
(Siemens Sonata; Siemens Healthcare, Erlangen, Germany). RF excitation pulses were
transmitted with the built-in scanner body coil. MR signals were received with a custombuilt single loop (80 mm ID) receive-only head coil, which was actively decoupled
during transmit. The animal was firmly secured to a custom-built head holder with a bite
plate to minimize motion during the study. The head coil was firmly fixed close to the
brain, over the dorsal aspect of the head.
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5.3.5 MRI Sequences
An interleaved BOLD/ASL sequence was implemented to acquire T2-weighted images
and CBF simultaneously.

A single-shot fast spin echo (FSE) readout was used with a

pseudocontinuous arterial spin labeling (PCASL) preparation without background
suppression (112,113). Although it produces lower BOLD contrast than T2*-weighting, a
fully-refocused T2-weighted FSE sequence was used to produce a very temporally stable
signal. The RF refocusing reduces sensitivity to main magnetic field drift, which can be
substantial over the long time periods (> 1 hour) used in this experiment. Furthermore,
complete RF refocusing of the signal also has the benefit of being insensitive to any B0
shifts induced by hyperoxia, as discussed in Chapter 2. The PCASL approach uses a
rapid pulsed method to produce spatially-varying effective B1 field along the direction of
the artery, similar to continuous ASL. This approach is preferred to the continuous
method since it has a superior approach for generating the control image (112), producing
higher overall efficiency and signal-to-noise ratios.

The FSE readout parameters were: TE/TR = 118 ms/4000 ms, FOV = 180 x 180 mm2,
Matrix = 64 x 64, BW = 130 Hz/Px, excitation flip angle = 900, refocusing flip angle =
1800, slice thickness = 8 mm. PCASL parameters were: labeling duration = 1500 ms,
post-label delay = 1000 ms, label plane offset = 60 mm, B1avg = 1.7 µT, Gavg = 6 mT/m.
The PCASL control and tag images were interleaved one-to-one.
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5.3.6 BOLD and Arterial Spin Labeling Analysis
All images were motion corrected before analysis with FSL tools (77) using a software
package designed to process intramodal MRI time series data (FEAT) (78). PCASL
controls were used as the BOLD images . Given that TR is about four to five times the
T1 of tissue at 1.5T, T1 weighting will be minimal and the images can be considered
entirely T2-weighted.

The control and tag images were subtracted, and the resulting PCASL ΔM data were
converted to CBF according to Eq. 5.1 (114):

[ 5.1 ]

where α is the inversion efficiency (assumed to be 0.9), M0a is the equilibrium
magnetization of blood, T1a is the longitudinal relaxation time of arterial blood, PLD is
the post-label delay time (time between the end of tagging pulse and beginning of the
readout), τ is the labeling duration, and T2a is the transverse relaxation time of arterial
blood.

As discussed in Section 4.3.3, M0a was calculated based on the local

magnetization using Eq. [4.3], with R = 0.98, T2a = 200 ms, and T2LT = 120 ms (23). T1a
under normoxia was taken to be 1350 ms (21), while the T1a during hyperoxia was
determined by the application of Eq. [3.2] based on the discussion in Chapter 3. It was
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assumed that relaxivity of both deoxyhemoglobin and molecular oxygen were
independent of field strength (21).

Final analysis of the BOLD and ASL data was performed using custom scripts written in
MATLAB. Due to the lower Boltzmann distribution, longitudinal relaxation time, and
deoxyhemoglobin relaxivity at low field, both the ASL and BOLD data were relatively
noisy. Given the limited signal-to-noise ratio of our measurements, we analyzed all
values using whole brain regions-of-interest that were manually drawn to cover both the
gray and white matter regions. Baseline values were calculated using a five minute
average before the stimulation, and stimulation values were a five minute average at the
end of the stimulation period. DNP stimulation values were calculated over five minutes
and centered at thirty minutes post-DNP administration.

5.3.7 Calculation of Regional Cerebral Metabolic Rate of Oxygen: Hyperoxic and
Hypercapnia Calibration Methods
We calculated relative CMRO2 changes in this study using the formalism introduced by
Hoge, et al. (107), which is based on the use of simultaneous BOLD and CBF data. This
method requires a known isometabolic dilution of deoxyhemoglobin (dHb).

An

isometabolic reduction in the concentration of dHb can be achieved with a gas inhalation
of hypercapnic or hyperoxic gas. The former dilutes dHb via an increase in flow, while
the latter dilutes dHb by raising the oxygen content of arterial blood. To calculate
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changes in CMRO2, it is necessary to develop a detailed physical model of the interaction
between CBF, CBV, and blood oxygenation their effects on the BOLD signal. A brief
derivation is provided below for the models of both hypercapnia and hyperoxia as first
shown by Hoge, et al. (107) and Chiarelli, et al. (6).

As discussed previously, the regional concentration of dHb is proportional to the
transverse relaxation time:

[ 5.2 ]

As Boxerman et al. (115) have shown, R2_dHb is proportional to the cerebral blood volume
and the concentration of venous dHb:

[ 5.3 ]

where A is a constant depending on field strength and local tissue properties; β is a
constant between 1 and 2 that depends on average blood volume. Consider a reduction in
R2,Hb from dHb dilution secondary to an increase in flow (via CO2 inhalation). The
change in R2,Hb versus non-baseline values can be expressed as:
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[ 5.4 ]

where the subscript ‘0’ defines the baseline steady state. The relationship between the
change in R2,Hb and the change in the measured BOLD signals is:

∆BOLD
= e−T E∆R2,dHb − 1
BOLD

[ 5.5 ]

If we assume that changes in R2,Hb are sufficiently small, we can make Eq. [5.5] linear, so
that:

[ 5.6 ]

Substitution of Eq. [5.4] into [5.6] yields:

[ 5.7 ]

Rearranging yields:

[ 5.8 ]
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The term (TE⋅A⋅CBV0⋅[dHb]v0) represents the fractional BOLD attenuation that occurs
from the dHb at baseline. Importantly, it also represents the maximum possible BOLD
response if all dHb was removed from tissue in its baseline state. For clarity, this
constant is expressed as M:

[ 5.9 ]

This model will assume a consistent relationship between the change in CBV and the
change in CBF. This relationship is also referred to as the Grubb relationship, where:

CBV
=
CBV0

�

CBF
CBF0

�α

[ 5.10 ]

where α is a constant equal to approximately 0.38 (116). Based on this relationship, the
relative CBV term from Eq. [5.8] can be measured by the change in the relative CBF
alone.

If we assume that the arterial blood has a negligible concentration of dHb, then the
concentration of dHb in a given tissue volume must be dependent entirely on CMRO2 and
CBF such that, according to mass conservation (Fick’s principle):

[dHb]v =

1 CM RO2
4 CBF
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[ 5.11 ]

	
  

where the factor of four is due to the fact that one molecular of dHb delivers four O2
molecules. In the case of isometabolism, the baseline-normalized change in [dHb]v can
be expressed as:

CBF0
[dHb]v
=
[dHb]v0
CBF

[ 5.12 ]

Substituting in Eqs. [5.10] and [5.12] into Eq. [5.8] yields an expression for the change in
the BOLD signal from baseline for a given change in the CBF from its baseline at a
constant rate of oxygen metabolism:

∆BOLD
=M
BOLD0

�

1−

�

CBF
CBF0

�α−β �

[ 5.13 ]

Since α is larger than β, there is a monotonic increase in the BOLD signal with perfusion.

In the case where metabolism is not constant, Eq. [5.12] is not valid, and the following
expression must be used instead:

[ 5.14 ]
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When substituting this expression into Eq. [5.8], we get an expression relating the relative
BOLD, CBF, and CMRO2:

[ 5.15 ]

In this way, we have an expression to relate the change in BOLD and CBF signals to the
change in CMRO2, which depends only on α and β values. We can obtain a value of the
calibration factor M by using an isometabolic change in flow, which can be achieved
with an increase in the arterial partial pressure of CO2. However, the accuracy of the
calculated M value will primarily depend on whether hypercapnia does, in fact, leave the
metabolic rate unchanged.

Since inhaling CO2 gas for calibration of Eq. [5.15] has its drawbacks, including the
potential alteration of metabolism, there has been interest in calculating M with oxygen
inhalation. This is known to produce far fewer physiologically effects. Chiarelli et al.
outlined a method to accomplish this, which requires the calculation of the relative
change in [dHb]v, as Eq. [5.11] is no longer valid during hyperoxia. To make this
measurement, we must know the degree of excess oxygen content in the arterial blood
during hyperoxia. We must also make some assumptions about baseline oxgyen
extraction fraction (OEF), which will be discussed below.
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As discussed in Chapter 4, short hyperoxic inhalation epochs produce an approximately
5% decrease in CBF after we correct for reduction in T1a. Therefore, reduction in CBF
with hyperoxia will directly affect [dHb]v change and produce a secondary effect on
CBV, both of which must be accounted for. To do this, we must add additional terms to
Eq. [5.8]:

∆BOLD
=M
BOLD0

�

1−

�

CBV + ∆CBV
CBV0

��

[dHb]v + ∆[dHb]v
[dHb]v0

�β �

[ 5.16 ]

where the additional CBV and [dHb]v are due to oxygen. Since CBV is not changed by a
change in [dHb]v, the additional term is equal to CBV0. Noting that:

[dHb]v
∆[dHb]v
=
−1
[dHb]v0
[dHb]v0

[ 5.17 ]

�

[ 5.18 ]

we can express Eq. [5.8] as:

∆BOLD
=M
BOLD0

1−

�

CBF
CBF0

�α �

�β �
CBF0
[dHb]v
+
−1
[dHb]v0
CBF

To calculate the baseline-normalized [dHb]v we must have knowledge of the arterial
blood saturation (SaO2) and the arterial partial pressure of oxygen (PaO2). The PaO2 can
either be calculated from the end-tidal oxygen level or directly measured via arterial
blood gas. The SaO2 can then be calculated from that PaO2 (84), or it can be measured
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directly via pulse oximetry. In this study, we calculated SaO2 with pulse oximetry and
PaO2 with blood gases. The oxygen content of arterial blood can be expressed as:

CaO2 = φ [Hb] SaO2 + P aO2 ε

[ 5.19 ]

where φ is the oxygen carrying capacity of Hb, assumed to be 1.34 mL02/gHb, ε is the
solubility coefficient of oxygen in blood, assumed to be 0.0031 mLO2/ dLblood/mm Hg
(84), and [Hb] is assumed to be 15 gHb / dLblood (117), in lieu of a direct measurement.
The first term represents the amount of oxygen carried by hemoglobin, while the second
term is the excess oxygen dissolved in the plasma. The outflow of arterial oxygen to the
venous system can be calculated again, analogous to the hypercapnia case above, by
assuming that hyperoxia is isometabolic and using Fick’s principle:

CBF · CV O2 = CBF · CaO2 − CBF0 · CaO2,0 · OEF0

[ 5.20 ]

where the baseline OEF0 is assumed to be approximately equal to 0.3 from 15O2-labeled
radiotracer studies in humans (117). This is considered to be a good approximation,
because while CBF and CMRO2 change across the brain, OEF is remarkably stable (6).
Rearranging the terms, we can show:

CV O2 = CBF · CaO2 −
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CaO2,0 · OEF0
�
�
CBF
CBF0

[ 5.21 ]

	
  

Similar to arterial oxygen content, the venous oxygen content can be expressed as:

CvO2 = φ [Hb] SvO2 + P vO2 · ε

[ 5.22 ]

Since only a negligible amount of oxygen in venous blood is not bound to Hb (even at
high FiO2), the second term can be ignored so that:

SvO2 =

CvO2
φ · [Hb]

[ 5.23 ]

The baseline-normalized expression for [dHb]v can be expressed as a ratio of SvO2
values:

1 − SvO2
[dHb]v
=
[dHb]v0
1 − SvO2,0

[ 5.24 ]

Again, to summarize, the calibration value M can be determined using hyperoxia by the
expression:

M=�

1−

�

∆BOLD
BOLD0

CBF
CBF0

�α �

[dHb]v
[dHb]v0

	
  
119	
  

+

CBF0
CBF

�β �
−1

[ 5.25 ]

	
  
where the baseline-normalized change in CBF is measured and corrected according to the
Chapter 4, and baseline-normalized expression for [dHb]v is calculated as shown above.
For the [dHb]v calculation of the hyperoxia calibration, SaO2 was determined from the
PaO2 measured by arterial blood gas.
M can also be obtained from hypercapnia calibration according to the expression:

M=�

∆BOLD
BOLD0

1−

�

CBF
CBF0

�α−β �

[ 5.26 ]

In this study, we assumed that α = 0.38 and that β = 1.5 for both calibrations, in
accordance with previous studies (6,107). Both of these expressions for M can be placed
in the original equation for calculating the change in CMRO2 proposed by Hoge et al.
(107):

�

CM RO2
CM RO2,0

�

=

�

1−

∆BOLD
BOLD0

M

�1/β �

CBF
CBF0

�1−α/β

[ 5.27 ]

Relative changes in CMRO2 were calculated using both hyperoxia and hypercapnia
calibrations using custom MATLAB scripts with Eq. [5.27] and the processed BOLD and
ASL data (as described above).
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5.4 Physiologic Responses to Hyperoxia, Hypercapnia, and DNP
Traces of the end-tidal CO2 (EtCO2), pulse oximetry arterial saturation (SpO2), and heart
rate (HR) from a representative animal are shown in Fig. 5.1. During hyperoxia, the
SpO2 clearly rose to complete saturation (99.7 ± 0.1 %). During both hypercapnia and
DNP administration, SpO2 typically stayed above approximately 95%. Hypercapnia
caused a substantial increase in EtCO2 from a baseline of approximately 40 (41.2 ± 3.4
mm Hg) to >60 mm Hg (66.2 ± 4.6 mm Hg). DNP caused an immediate and steady
increase in EtCO2 after infusion. Before DNP injection, HR typically stayed constant at
approximately 80 beats per minute (bpm). After DNP injection, HR increased steadily
and was approximately 130 bpm thirty minutes after DNP infusion.
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Figure 5.1. Physiological monitoring traces from a representative animal over the
entire experiment.

The shaded green area represents hyperoxia, the red area

represents hypercapnia, and the blue area represents post-DNP injection. End-tidal
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CO2 increased significantly during CO2 breathing and after DNP injection. Oxygen
saturation measured with pulse oximetry was increased to maximum values during
hyperoxia, and otherwise remained in the normal physiological range (~93-98%) at
all times. There was a consistent trend toward some slight desaturation during
hypercapnia and saturation level instability after DNP injection. This is most likely
due to the animal resisting mechanical ventilation from high arterial levels of CO2.
Note that oxygen consistently displayed faster wash-in and wash-out times
compared to carbon dioxide. The heart rate remained relatively stable during gas
challenges, but increased steadily after administering DNP.

5.5 Arterial Blood Gases
The results of the arterial blood draws taken during the experiment are shown in Table
5.1. The blood draws for gas challenges were taken at the very end of the inhalation
epoch, while post-DNP draws were taken at approximately thirty minutes after the DNP
was infused. All values were tested against the baseline using a two-tailed, paired
Student t-test. Hyperoxia had a statistically significant increase only in PaO2, while both
hypercapnia and DNP injection produced a significant increase in PaCO2 and decrease in
pH.
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Table 5.1. Arterial Blood Gas Parameters for Hyperoxia, Hypercapnia, and PostDNP Infusion
pH

pO2 (mm Hg)

pCO2 (mm Hg)

SaO2 (%)

Baseline

7.48 ± 0.08

102 ± 10

38.1 ± 6.6

98.1 ± 1.1

Hyperoxia

7.49 ± 0.12

524 ± 42*

42.2 ± 5.1

100 ± 0*

Hypercapnia

7.31 ± 0.05*

101 ± 9

62.3 ± 4.6*

96.2 ± 2.5

DNP

7.22 ± 0.11*

108 ± 9

81.7 ± 17.2*

96.6 ± 0.9

*

P < 0.05 from baseline

5.6 BOLD and CBF Responses to Hyperoxia, Hypercapnia, and DNP
Absolute values of CBF were calculated according to Eq. [5.1] and Section 5.3.7. The
baseline state across the brain was found to be 39.4 ± 7.8 mL/100 g tissue/min. Relative
changes are reported below, as they are the focus of this study. Where indicated, CBF
has been corrected for T1a according to the approach in Chapter 4, assuming a baseline
T1a = 1350 ms (21).

The regional changes from baseline in BOLD and CBF from a representative animal are
shown in Fig. 5.2, with overlays onto the structural images. Change in the CBF after
correction for T1a was found to be a small reduction, in agreement with findings in
Chapter 4. Hyperoxia increased the BOLD response, but less than hypercapnia, which is
in agreement with prior studies showing significantly smaller BOLD responses in similar
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experiments (38). Hypercapnia increased the CBF by at least a factor of two, which is in
agreement with the widely measured relationship of approximately 5% increase in CBF
per mm Hg of CO2 (118). Similar to hypercapnia, DNP showed an increase in flow at
thirty minutes that is greater than two-fold, but showed a substantially lower BOLD
change. This response is predicted by the biophysical model of the BOLD signal given
above. As the CMRO2 increases substantially with DNP, the local concentration of dHb
also increases, decreasing T2 and counteracting the T2 increase from the increase in CBV
(107).
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Figure 5.2. Baseline-normalized changes in BOLD and CBF for each experimental
condition.

The color scales represent the percent signal change from baseline.

Hyperoxia showed a mild reduction in CBF and an increase in the BOLD, which
was less than that for hypercapnia. Hypercapnia yielded an approximately two-fold
increase in CBF. DNP measurements were taken approximately thirty minutes
after drug infusion. The CBF increase during DNP was approximately equivalent
to that after the ten minute hypercapnia challenge, while the BOLD signal was
approximately around baseline levels.

Fig. 5.3 shows MRI signal responses of an ROI that is drawn over the whole brain from a
representative animal (same as in Fig. 5.1), using the control and control – tag images.
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The relative BOLD (control) signal yielded very good stability over the course of the
initial baseline period. This is likely due to the use of the FSE sequence, which is
insensitive to B0 changes, thereby making it much more temporally stable than other
acquisition approaches. The BOLD signal increased approximately half as much during
hyperoxia as compared to hypercapnia. Again, a slight decrease in the relative CBF
(control – tag) images was observed during hyperoxia (Fig. 5.3 data not yet corrected for
T1a), although the extent of the change varied across animals. After DNP injection, the
BOLD signal initially stayed approximately stable, but then decreased. The CBF signal
showed a steady increase from baseline until the animal was euthanized.
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Figure 5.3. MRI signal traces from a whole brain ROI of a representative animal
(same animal as Fig. 5.1). The shaded green area represents hyperoxia, the red area
represents hypercapnia, and the blue area represents post-DNP injection.
Hyperoxia resulted in a BOLD (control) signal increase, while showing a slight
decrease in CBF (control – tag). Hypercapnia was increased in both BOLD and
CBF. Post-DNP injection, the BOLD signal was stable and then decreased, while
the CBF signal constantly increased until the end of the experiment.
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5.7 Calculation of the Calibration Factor M for Hyperoxia and Hypercapnia
We calculated a value of M for each animal according to Eqs. [5.25] and [5.26]. The
relative changes in the ΔBOLD/BOLD0, CBF/CBF0, [dHb]v/[dHb]v0 (for hyperoxia only),
and M for all experimental animals are shown in Tables 5.2a and 5.2b. As mentioned
above, hyperoxia had slightly more than half of the BOLD signal changes compared to
hypercapnia. CBF was more than doubled during hypercapnia, while a slight decrease of
approximately 5% occurred during hyperoxia after correcting for T1a. The average value
of M calculated with hyperoxia was determined to be significantly lower (P < 0.001) than
that calculated during hyperoxia. The coefficients of variation for M were found to be
higher for hyperoxia than hypercapnia.
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Table 5.2a. Calculation of Calibration Factor M with Hyperoxia†
Animal

CBF/CBF0

ΔBOLD/BOLD0 (%)

dHb/dHb0

M

1

0.945

0.915

0.719

2.05

2

0.918

0.917

0.692

1.81

3

0.952

0.778

0.732

1.84

4

0.978

1.13

0.703

2.61

5

0.875

1.36

0.732

2.71

6

0.943

1.11

0.670

2.18

7

0.982

1.08

0.630

2.08

8

0.949

1.35

0.666

2.66

m ± SD

0.946 ± 0.038

1.13 ± 0.21

0.689 ± 0.041

2.35 ± 0.36

CoV (% m/SD)

4.06

18.8

5.94

15.4

†

m is the mean, SD is standard deviation, and CoV is coefficient of variation
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Table 5.2b. Calculation of Calibration Factor M with Hypercapnia†
Animal

CBF/CBF0

ΔBOLD/BOLD0 (%)

M

1

1.90

1.34

2.62

2

2.54

1.90

2.92

3

2.38

1.72

2.78

4

2.45

2.45

3.87

5

2.15

1.91

3.32

6

1.98

1.63

3.05

7

1.99

1.79

3.32

8

1.64

1.34

3.14

m ± SD

2.10 ± 0.29

1.81 ± 0.37

3.24 ± 0.37

CoV (% m/SD)

14.1

20.5

11.3

†

m is the mean, SD is standard deviation, and CoV is coefficient of variation

5.8 CMRO2 Calculation with Hyperoxia and Hypercapnia
Fig. 5.4 shows traces of CMRO2 changes versus time, immediately after DNP
administration of a whole brain ROI for hyperoxia and hypercapnia. The traces were
determined according to Eq. [5.27] and the values of M were calculated above. As is
visible from the traces, the change in CMRO2 is similar for both of the calibration
methods despite the significant difference in calculated M values.
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Figure 5.4. CMRO2 signal traces from a whole brain ROI from a representative
animal immediately after DNP infusion. Values are in percent difference from the
baseline. The blue trace is calibrated from hyperoxia, and the black trace is from
the hypercapnia calibration.

Fig. 5.5 illustrates regional changes in CMRO2 from a representative animal
approximately thirty minutes after DNP with the hyperoxia calibration. Increases in
CMRO2 were visualized mainly around the large increases in cortical flow, as shown in
Figure 5.2. The average increase in CMRO2 approximately thirty minutes after DNP is
shown in Table 5.3 for both hyperoxia and hypercapnia calibrations.
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Figure 5.5. CMRO2 change after thirty minutes of DNP administration in percent
increase from baseline.

A structural image (left) is shown with an overlay of

CMRO2 increase (right). CMRO2 appears to increase globally across the brain,
with the largest increases occurring in the cortex.
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Table 5.3. Calculation of Relative CMRO2 After DNP Infusion†
Animal

CBF/CBF0

ΔBOLD/BOLD0 (%)

HC CMRO2 (%)

HO CMRO2 (%)

1

–

–

–

–

2

4.13

0.474

156

135

3

2.51

-0.859

138

156

4

2.50

0.0597

96.4

95.4

5

2.06

-2.49

149

165

6

–

–

–

–

7

2.32

-1.51

141

170

8

3.03

-0.554

155

159

m ± SD

2.76 ± 0.74

0.814 ± 1.076

139 ± 22

147 ± 28

†

m is the mean, SD is standard deviation, and CoV is coefficient of variation

5.9 Chapter Discussion
In this study, the relative CMRO2 changes in a hypermetabolic swine model were
measured using simultaneous BOLD and ASL data, calibrated with isometabolic dHb
dilution using inhaled oxygen and carbon dioxide. Using this method, we observed rapid
and steady increases in CMRO2 after administering DNP. The CMRO2 increase at thirty
minutes was found to be slightly less than that from a prior study using 17O2 inhalation.
However, both methods show an approximate 150% increase in CMRO2 after thirty
minutes of 9 mg/kg DNP.
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We found that hyperoxic and hypercapnic approaches to calibration produced very
similar final CMRO2 estimations.

However, there were important observed

inconsistencies between the methods. First, the calculated M values were significantly
different between the methods, a finding consistent with prior studies (6,38,39). The M
calculated here were lower for hyperoxia than for hypercapnia, which is same trend seen
in prior studies (39). There are several potential explanations for this discrepancy. The
difference may be caused by a change in OEF during anesthesia from the assumed value
of 0.3. The hyperoxic calculation of M is known to be very sensitive to this parameter
(6), and an underestimated OEF will significantly decrease the calculated M value (Eq.
[5.20]). Another reason for this difference may be the uncertainly of the value of alpha
(39), since hypercapnic calculation M is sensitive to this parameter while the hyperoxic
calculation is not.

Second, the coefficients of variation were higher for hyperoxia than for hypercapnia
which is the opposite finding compared to prior studies (39).

The reason for the

difference may lie in the determination of PaO2. Prior studies inferred PaO2 from the
end-tidal oxygen concentration (EtO2), which may yield artifactually consistent results
whereas arterial blood gas is far more sensitive and accurate measurement of PaO2. Also,
since this study involved mechanical ventilation and anesthesia, it may have produced a
far more consistent CO2 increase and response compared to free breathing humans (39).
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There are several distinct advantages to using hyperoxia over hypercapnia. First, as we
observed in our experiment, oxygen exhibits much faster wash-in and wash-out times as
compared to carbon dioxide. This is most likely because excess oxygen has much lower
solubility in blood and tissue compartments compared to carbon dioxide (37). Also, in
many animals, the wash-in of CO2 was so slow that the plateau period of MRI signal
response was not reached during the ten minute hypercapnic epoch. This is important
because a dynamically changing signal can introduce additional error into the calibration.
Furthermore, the slow wash-out times mean that hypercapnia requires more rest time to
return to physiologic baseline, substantially increasing the time required for the
calibration measurement compared to hyperoxia.

Second, there is significantly less controversy in the literature that hyperoxia is
isometabolic (5) compared to hypercapnia (119,120). It is crucial to this calibration
model that hyperoxia and hypercapnia produce isometabolic changes in dHb
concentration; any metabolism changes during the gas inhalation would invalidate a
central assumption of the calibration model. Third, the hypercapnia model depends on an
accurate measurement of flow changes during gas inhalation. Perfusion measurements
with ASL, especially when resolved for regional analysis, are much noisier than BOLD
measurements at the same resolution. Since hyperoxia calibration results in only small
reductions in flow, it is insensitive to perfusion data and its associated noise. Fourth,
compared to hyperoxia, the hypercapnia calibration is much more sensitive to the
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assumed value of alpha from the Grubb relationship, which is a matter of controversy
(39).

It should be noted that BOLD/ASL data like this is typically used for fMRI experiments
with repeated stimulation paradigms at a relatively high frequency (on the order of
around a minute). The experiment done here is more challenging, because it uses a single
stimulation occurring over a much longer period of time. In this case, the results are
much more sensitive to low frequency noise because the data cannot be passed through a
high-frequency filter that is typically employed in repeated stimulation paradigm fMRI
experiments (38). This limitation was successfully overcome, however, by reducing low
frequency noise using a fully refocused FSE acquisition. This dramatically reduced our
sensitivity to B0 shift over time, which is the main source of low frequency noise in
standard T2*-weighted BOLD experiments.

Although a regional analysis was not performed in this study, studies performed at high
field should allow for higher resolution measurements due to higher overall signal-tonoise and higher BOLD contrast. Furthermore, it should be noted that swine have
smaller brains for their body size compared to humans or primates. Experiments using an
animal with a larger brain would likely allow for a low-resolution regional analysis, even
at this field strength.
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In conclusion, we have shown that it is feasible to measure CMRO2 changes using
simultaneous BOLD/ASL data, as calibrated with hyperoxia or hypercapnia.

Both

hyperoxia and hypercapnia calibrations produced very similar CMRO2 changes, despite
producing slightly different measurements of the calibration constant M. Hyperoxia
exhibited substantially faster wash-in and wash-out times than hypercapnia, allowing for
a much more rapid establishment of equilibrium conditions. Compared to measurements
using 17O2 inhalation in the same animal model and experimental conditions, we showed
comparable increases in CMRO2 with this calibrated BOLD/ASL method. A superior
experiment for cross-validation would be to simultaneously use both methods in the same
animals.

Due to the need to first determine the feasibility of relative CMRO2

measurements using calibrated BOLD/ASL data in this context, as well as the expense of
17

O2 gas, this was not done for these initial studies. However, given that we have shown

the feasibility of this approach, this will be the goal of future work. Moreover, the
advancements made in this study will allow for more accurate cross-validation studies
using simultaneous MRI measurements of CMRO2 using 17O2 and BOLD/ASL data.
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Chapter 6: Dependence of Cerebral Blood Flow and Oxygen
Consumption on Hyperoxia-Induced Changes
in the Longitudinal Relaxation Time

6.1 Overview
This chapter aims to develop a biophysical model that relates blood flow and oxygen
consumption to the observed T1 decrease in tissues during hyperoxia. Showing opposite
trends compared to hyperoxic effects on R2 (BOLD), hyperoxic R1 enhancement
increases as CBF increases and metabolism decreases. Using hypercapnia to induce an
isometabolic increase in CBF, our model captures effects on R1 due to this physiological
parameter during hyperoxia. Since a comprehensive validation of this model requires
measuring hyperoxia as a function of metabolism, future work will focus on altered
metabolic states.

6.2 Introduction
Tumor oxygenation and the methods to improve it are important in clinical oncology,
because tumor hypoxia modulates radiation responsiveness and limits the effectiveness of
radiation therapy (121). Hyperoxic contrast is an attractive method of studying tumor
oxygenation because other methods capable of imaging oxygen, such as PET (122),
electron paramagnetic resonance imaging (EPRI) (123), and
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F compounds (124), are

	
  
much more expensive, are much more difficult to use, and/or are restricted to animal
studies. While most studies of tissue lesions, including ischemic stroke and tumors, have
focused on the ability of oxygen to dilute dHb and increase T2 (67,125), there have been
several recent studies using hyperoxia primarily to decrease T1 with dissolved molecular
oxygen in order to study tissue oxygen delivery to normal tissue and tumors (31,32,67).

Studies using hyperoxic R1 enhancement have shown large heterogeneities between
tissue types in the ability of oxygen to increase R1 (32,33). Although qualitative means
to explain these differences have been proposed, such as differences in blood flow rate
and/or blood volume (31), no attempts have been made to develop a quantitative
understanding of the relationship between hyperoxic R1 enhancement and major
physiologic parameters including blood flow, blood volume, and oxygen consumption.
An understanding of these relationships is crucial to a more rigorous interpretation of
hyperoxic R1 enhancement and a more rational approach to its clinical use.

In this study, we set out to take the first steps toward developing a detailed quantitative
biophysical model of R1 relaxation enhancement in vivo.

To accomplish this, we

followed a line of reasoning that is similar to the one used in the development of
quantitative models of deoxyhemoglobin concentration with hyperoxia (6,39).

Our

central premise is that dissolved oxygen R1 contrast within a volume of tissue is
dependent solely on the increase in plasma and tissue concentration of oxygen, which in
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turn will depend primarily on the volume of blood and its concentration of oxygenated
hemoglobin. This is because oxygenated blood is the only place where excess dissolved
oxygen can exist. Therefore, we expect to see the increased hyperoxic R1 enhancement
where either blood volume or the concentration of oxygenated hemoglobin is elevated.

Although we focus our study on measurements made in the cerebral tissue (CBF, CBV,
and CMRO2), basic conclusions of our biophysical model could be applied to any tissue
type exhibiting a similar flow, volume, and oxygen consumption relationship. We tested
this model using an isometabolic increase in CBF using hypercapnia. To complete a test
of this model, it will also be necessary to study the relationship of R1 enhancement to
changes in CBF and CMRO2, examining whether they differ from the CBF response
alone.

6.3 Theory
The biophysical model first developed by Hoge, et al. (107) establishes a relationship
between R2, CBF and CMRO2 based on the expected changes in dHb concentration and
CBV. In a similar manner, we have attempted to produce a quantitative model relating
R1 changes during oxygen inhalation to CBF and CMRO2, based on the expected change
in oxyhemoglobin concentration (HbO2) and CBV. Following a similar line of reasoning
to Hoge, et al. (107), we developed an approach to determine the amount and distribution
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of molecular oxygen in tissues. We can consider the longitudinal relaxation observed in
tissues to be the sum of the components of R1 caused by molecular oxygen and a
contribution caused by other sources:

[ 6.1 ]

It is crucial to this model that we can describe an accurate relationship between the
steady-state R1 contribution of oxygen and the underlying physiological parameters. We
argue that we can accurately model the effect of oxygen in following way:

[ 6.2 ]

where r02 is the relaxivity of molecular oxygen (s-1 mm Hg-1) and λ is a tissue specific
constant relating the concentration of oxygen in the blood to its concentration in tissue.
The constant λ will depend on several physical processes, including the ability of oxygen
to diffuse into tissue and its absorption by dHb. Although it does not represent a
complete physical picture, we argue that this relationship is approximately accurate, since
the dominant source of molecular oxygen in tissues is from the plasma of oxygenated
blood.

If we increase the concentration of oxygen only in the arterial blood, and we assume no
changes in the CBV, CBF, CMRO2, then:
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[ 6.3 ]

where the subscript ‘0’ takes its normal meaning as the initial state. We expect this
quantity to be positive, since adding oxygen will reduce T1. It should be pointed out that
this is only approximately correct for a few reasons. First, the excess oxygen will
increase the concentration of HbO2. However, this change will be small under hyperoxic
inhalation and only have a small effect on the measured R1. The contributions of local
blood volume and λ are expected to dominate over the influence of HbO2 in this context.
Second, this treatment ignores the potential effect of dHb concentration on R1. The
dilution of dHb is expected to decrease R1, because dHb is paramagnetic. However, this
effect is again expected to be small in relation to the increase in R1 from oxygen in the
blood and tissue. Third, any the reduction in CBF during hyperoxia is also ignored, as
the small effects it may have on R1 through changes in CBV or [HbO2] are also
dominated by the effects of dissolved oxygen.

We now want to relate the change in R1 that occurs at a single hyperoxic inhalation where
CBV, CBF, and CMRO2 are held constant versus when these parameters are changed.
We will refer to this process as ΔΔR1, since we are comparing the change (at different
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physiological conditions) of the change (at the same physiological conditions with
hyperoxia) in R1:

[ 6.4 ]
It is important to remember that the fundamental measurement is ΔR1, which represents
the difference in R1 due to hyperoxia alone, without other changes. ΔΔR1 is the change in
ΔR1, not at different levels of hyperoxia, but at different physiological conditions.

Similar to Eq. [5.11], if we assume a steady-state and Fick’s principle, there exists a
relationship between the local concentration of HbO2, CMRO2, and CBF:

[ 6.5 ]

If we assume that the CMRO2 does not change, then we can express the ratio of [HbO2]
as:

[ 6.6 ]

and if we also assume Grubb’s relationship (Eq. [5.10]), we can rewrite Eq. [6.4] as:
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[ 6.7 ]

where E is:

[ 6.8 ]

In the more general case where CMRO2 is not constant, then Eq. [6.6] must be replaced
with:

[ 6.9 ]

Using Eq. [6.9], we can rewrite Eq. [6.7] to include the influence of CMRO2:

[ 6.10 ]

From studying Eq. [6.10], we can see that the behavior of change in R1 is different than
that observed for BOLD contrast during hyperoxia. In BOLD-modulated studies using
hyperoxia, the degree of R2 contrast that can be generated is directly proportional to the
concentration of dHb in the voxel.

As CMRO2 increases or CBF decreases, the

concentration of dHb will increase, as will the ability to generate BOLD contrast with
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hyperoxia. With R1 contrast, the opposite occurs, since the degree of contrast that can be
generated depends on the concentration of HbO2.

As CMRO2 decreases or CBF

increases, the degree of R1 contrast generated with hyperoxia will also increase.

The relationships between ΔΔR1, CBF, and CMRO2 as derived in Eq. [6.10] are
illustrated in Fig. 6.1. It was assumed that the (PaO2/PaO2,0) = 4 in all cases. For the
same CMRO2, an increase in the relative CBF increases the R1 contrast from hyperoxia
inhalation. Also, as can be seen from Eq. [6.10], this behavior is not asymptotic, since an
increase in CBF increases the CBV and [HbO2] continuously. However, there is a
physiological limit of CBV increases and [HbO2] that can occur in tissue, so this
relationship will only hold over a certain set of physiologically determined bounds. For
increases in CMRO2, we expect the concentration of [HbO2] to be reduced, which
reduces the sensitivity of R1 contrast. As CMRO2 decreases for the same CBF, there will
be increased concentrations of [HbO2], increasing the sensitivity of R1 contrast. Again,
this is also subject to a physiological limit, since there is a point beyond which no
increase in [HbO2] will occur.

	
  
146	
  

	
  

Figure 6.1. The relationships between ΔΔR1, CBF, and CMRO2 as derived by Eq.
[6.10]. There is increased hyperoxia-induced R1 contrast at higher flow rates and
lower levels of CMRO2.

6.4 Materials and Methods
The main purpose of this study was to determine if our model of hyperoxia-induced
changes in T1 accurately describes the contrast in vivo. We set out to measure the effect
of an isometabolic increase in CBF using hypercapnia on the measured R1 contrast. If
our model is correct, we expect to see an approximately linear change in ΔΔR1 versus
CBF.
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6.4.1 Animals
All experiments performed were part of an approved protocol by our Institutional Animal
Care and Use Committee. All data were obtained on adult male Sprague-Dawley rats
(n=7; 370-440 g; Charles River, MA, USA).

Inhalation anesthesia was induced and

maintained in the same manner as described in Section 3.3.2. To ensure that physiologic
stability was maintained and to prevent oxygen desaturation, animals were maintained
with a minimum FiO2 of 0.3 (normoxia in this study). Gases were delivered and altered,
temperature was maintained constant, and head movement was restricted as described in
Chapter 3.

6.4.2 Hyperoxia and Hypercapnia Inhalation Challenge Paradigms
To generate an isometabolic increase in CMRO2, animals were ventilated in a steadystate manner with increasing levels of hypercapnia. Starting at with normoxia, animals
were ventilated with 5%, 10%, 15%, and 20% CO2 to generate four increased
isometabolic levels of perfusion. Five minutes was allowed after switching hypercapnia
levels before data was collected to allow for physiological adjustment to the new gas
condition.

During each of these steady state levels of hypercapnia, two oxygen

challenges from FiO2=0.3 to 0.8 were delivered in a baseline (5 min) – stimulation (10
min) – rest paradigm. In this way, we sought to increase the arterial partial pressure of
oxygen by approximately the same amount for each hypercapnic epoch. Data from the
first two minutes of the oxygen challenge were discarded to allow time for the
equilibrium of oxygen wash-in.
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6.4.3 MRI Hardware
All imaging experiments were performed using a whole-body clinical 3T MRI scanner
(Siemens Trio; Siemens Healthcare, Erlangen, Germany) as in Chapter 3.

6.4.4 Measurement of CBF During Hypercapnia
We assumed that the brief hyperoxia inhalation epochs would not cause significant
decreases in CBF based on our prior work as outlined in Chapter 4. Furthermore,
changes in CBF due to hypercapnia were expected to dominate these changes, making the
correction of CBF during hyperoxia insignificant in this context. CBF was measured for
a six minute period before and after two oxygen challenges. CBF values were measured
using the PICORE-Q2TIPS method with a FSE readout as outlined in Section 4.3.3, with
the only difference being that we used a higher spatial resolution single-slice FSE readout
here, which also improved temporal resolution. This approach has the advantage of
minimizing sensitivity to transit time, which is particularly important in this case since
transit time will decrease substantially at higher flow rates. The imaging parameters
were: TI1 = 900 ms, TI1S = 1475 ms, TI2 = 1500 ms, TE/TR = 21/4000 ms, slice
thickness = 2 mm, FOV = 40 ×	
   40 mm, matrix size = 128 ×	
   128, and partial Fourier
factor = 5/8.
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6.4.5 Measurement of the Longitudinal Relaxation Time
The longitudinal relaxation time was measured with a single-slice fast gradient echo
Look-Locker technique (also referred to as snapshot-FLASH (30)). A 15 ms adiabatic
inversion pulse was used to invert the spins and was followed by fifteen low-angle fast
gradient echo readouts each lasting approximately 400 ms each and 1500 ms for the
signal to return completely to equilibrium. Magnitude and phase images were collected
to allow for a zero-crossing fit. The slice was co-localized to the ASL slice and the
sequence parameters were: flip angle = 40, slice thickness = 2 mm, FOV = 40 ×	
   40 mm,
matrix size = 64 ×	
  64, TE/TR: 2.2/400 ms, BW: 260 Hz/Px, and Look-Locker repetition
time = 8000 ms.

6.4.6 Data Analysis
All images were analyzed using routines and scripts written in MATLAB (MathWorks,
Inc.). Relative CBF maps were generated for each hypercapnic gas condition according
to Eq. [4.1]. We did not calculate absolute CBF values since only the relative changes in
CBF were important for this study.

We calculated T1 values for each Look-Locker

dataset according to the following equation:

−t/T1∗

Mz (t) = A − B · e
where T1 can be calculated according to (126):
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T1 = T1∗

�

�
B
−1
A

[ 6.12 ]

Mz was considered to have a positive or negative value depending on its relative phase.
Look-Locker images were averaged for normoxia and hyperoxia at each level of
hypercapnia. Per voxel T1 fits were performed on these data. Using the CBF maps, a
ROI was manually drawn to include the whole brain. Using these ROIs, we calculated
whole brain change in R1 between normoxia and hyperoxia. We calculated whole brain
values primarily due to the low resolution of our T1 data. We determined whole brain
values for CBF using these same ROIs.

6.5 Cerebral Blood Flow versus Hypercapnia Level
Relative values of cerebral blood flow were calculated according to Eq. [4.1] and Section
4.3.3 and are shown in Fig. 6.2. The single slice acquisition improved signal-to-noise per
unit time over previously acquired maps (Chapter 4), allowing for good regional analysis
of CBF. Global increases in CBF were observed, with the largest increases occurring in
the cortex, as expected.

CBF increased approximately monotonically with the

concentration of inspired CO2, without reaching a plateau. Hypercapnia increased CBF
by 27 ± 12 %, 63 ± 14 %, 94 ± 15 %, and 118 ± 17 %, for 5%, 10%, 15%, and 20% CO2
inhalations, respectively.
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Figure 6.2. Relative CBF (in arbitrary units) at each hypercapnia level from a
representative animal with a co-registered structural image (a).

CBF maps

correspond to baseline (b), 5% (c), 10% (d), 15% (e), and 20% (f) CO2 inhalation.

6.6 T1 Mapping
An example quantitative T1 map calculated according to Eqs. [6.11] and [6.12] is shown
in Fig. 6.3. This map was acquired during normocapnia and normoxia; T1 values of
1200 to 1300 ms measured in the cortex are in agreement with published values
(127,128). However, note that the noise for T1 maps was substantially higher than for the
ASL data, compromising our ability to perform regional analyses of the change in T1
during hyperoxia.
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Figure 6.3. Quantitative T1 map from a representative animal (right) with a coregistered structural image (left). T1 maps were significantly noisier than CBF
maps, but allowed for visualization of regional T1 values.

6.7 Hyperoxia-Induced R1 versus CBF
At baseline, oxygen inhalation induced a change in R1 from baseline by approximately
7.2 ± 1.8 × 10-3 s-1. Based on our previously determined relaxivity of oxygen as 1.61 ×
10-4 s-1 mm Hg-1, this change seems reasonable, since it is approximately 10% of the
change we expected to measure in the arterial blood for an increase in PaO2 from 100 mm
Hg to 500 mm Hg. The ΔR1 of hyperoxia was determined to be 10.2 ± 2.1 × 10-3, 14.4 ±
1.5 × 10-3, 18.2 ± 1.9 × 10-3, and 21.5 ± 2.4 × 10-3 s-1 for 5%, 10%, 15%, and 20% CO2
inhalations, respectively.

Using previously measured oxygen relaxivity, we can

determine that partial pressure of oxygen increased during hyperoxia by 43, 63, 89, 113,
and 133 mm Hg for the baseline state and 5%, 10%, 15%, and 20% CO2 inhalations,
respectively. The trace of ΔΔR1 versus the percent change in CBF is shown in Fig. 6.4.
A fit to the model using Eq. [6.7] showed very close agreement to the experimental data.
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Figure 6.4. The change in hyperoxic longitudinal relaxation enhancement (ΔΔR1)
versus relative change in the CBF (% increase from baseline). ΔΔR1data appears to
increase monotonically with CBF, and shows close agreement the proposed
biophysical model.
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6.8 Chapter Discussion
In this work, we have developed a biophysical model relating CBF, CBV, and CMRO2 to
the hyperoxic R1 enhancement. Measurements made during an isometabolic increase in
CMRO2 were in close agreement to our model. Furthermore, we can conclude from this
study that increasing the blood flow does increase the amount of excess oxygen delivered
to tissues. This is an important finding since the relationship between tissue flow and
oxygenation enhancement with hyperoxia is still somewhat controversial (31). Although
this does not recommend the use of CO2 for all tumors, as it does not vasodilate in all
types of cancerous tissue, it highlights the importance of increasing blood flow to
maximize tumor oxygenation.

It is important to note that the behavior of hyperoxic R1 contrast is the opposite of
hyperoxic R2 (BOLD) contrast. As CMRO2 increases at the same CBF, we expect the
sensitivity of BOLD contrast to increase because the deoxyhemoglobin concentration
increases (see Eq. [5.27]). Also, as CBF decreases at the same CMRO2, we expect to see
BOLD contrast sensitivity increase, since that will also increase deoxyhemoglobin
concentration. In this way, in relation to physiological conditions, R1 provides contrast
that is complementary in sensitivity to BOLD.
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To test our model completely, the response of R1 to changes in CBF and CMRO2 also
should be examined. The model predicts that a decrease in metabolism will also increase
the measured R1 contrast. There are several ways to accomplish this using our current
animal model, but the easiest protocol might be to induce moderate hypothermia, which
is known to significantly decrease aerobic metabolism (129,130). The same experiment
performed here could then be conducted during hypothermia, and, if our model is correct,
the relationship between ΔΔR1 and CBF should show a higher slope.

If our hypothesis is correct, this model also provides further explanatory power for why
hyperoxic R1 contrast is higher in some tumor regions. Tumors often undergo a switch to
increased anaerobic metabolism as part of their path to malignancy (131). As tumors
consume less oxygen, the model predicts that R1 contrast will also increase due to higher
concentrations of oxygenated hemoglobin. This can explain why significant hyperoxic
R1 enhancement occurs in some tumor regions despite relatively low levels of flow (33).
Our model suggests that since these regions exhibit significantly lower aerobic
metabolism, they may still show significant hyperoxic R1 enhancement despite lower
blood flow to the region.

It is important to note that the Bohr effect, which decreases the affinity of hemoglobin for
oxygen at higher CO2 levels, may be responsible for at least some of the observed
increases in hyperoxic R1 enhancement. If there is less oxygen bound to hemoglobin in
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the tissue, we expect to see larger increases in R1 enhancement due to the increase in
dissolved oxygen. Unfortunately, we cannot determine how much of our observations
are due to this effect. To eliminate the effect of Bohr shift on this experiment would
require the use of another arterial vasodilator that does not affect tissue pH or interact
with hemoglobin.

In conclusion, this study represents the first steps toward a complete biophysical model of
the relationship between hyperoxic R1 enhancement and blood flow, blood volume, and
metabolism. The model shows that hyperoxic R1 enhancement is expected to increase
with higher blood volume, blood flow, and decreased tissue oxygen consumption, which
is the opposite effect expected with BOLD contrast, providing complementary sensitivity
in relation to physiological conditions. We have shown that this model provides an
accurate description of the relationship between hyperoxic R1 enhancement and
isometabolic increases in CBF.

A comprehensive test of this model will require

examining the relationship of CBF and R1 relaxation in the setting of altered metabolism.
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Chapter 7: Summary and Future Directions

7.1 Future Directions
Although we have already mentioned several important future directions for this work in
the preceding chapters, we summarize and expand on these thoughts here and supplement
our discussion with some additional considerations.

The work in Chapter 2 of hyperoxic BOLD contrast can be improved by increasing the
range of FiO2 levels studied, particularly at ultra-high field.

Susceptibility-induced

distortions rise substantially as field strength increases, but the BOLD contrast also
increases. Our work indicates that 50% oxygen is optimal for generating BOLD contrast
at 3T with minimal oxygen susceptibility-induced errors. However, acceptable hyperoxia
levels for BOLD contrast in these experiments are likely to be even lower at 7T. This is
important, as it also reduces the physiologic effects of oxygen that can compromise the
accuracy of data and reduce the likelihood of any adverse events.

The main future goal of studies described in Chapters 3 and 4 is to implement brief T1a
measurements in human subjects that can be added to ASL study protocols.

As

discussed, the major technical hurdle is the inflow of inverted spins from outside of the
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transmit volume. Some approaches may circumvent this problem. If only early inversion
preparation times are used, it is technically possible that inflow of fresh spins can be
avoided. It is difficult, however, to determine the time it takes for fresh spins to enter the
tagging region. One approach to estimate this time would be to use arterial spin labeling
methods that sample the entire inflow curve (132) with the global inversion pulse
preparation. If the end of the inflow curve can be determined, this time would correlate
with the entry of uninverted spins. Using this information, it may be feasible to estimate
the time it takes for uninverted spins to enter the tagging region. Since the acceptable
inversion times before the arrival of uninverted spins are likely to be quite short, a more
accurate method of determining the T1a value may be to use these values to fit the zerocrossing point.

Future studies of hyperoxia calibrated BOLD/ASL experiments in our animal model will
incorporate simultaneous

17

O2 inhalation measurement of metabolism. Although our

hyperoxia calibrated measurements of relative metabolism compare favorably to
metabolic increases previously measured in the same model with 17O2 inhalation, minor
differences in animal preparation, including the time course of DNP administration, depth
of anesthesia, and other sources of physiological variation between animals will have
significant effects. Simultaneous measurements can allow us to greatly reduce these
variations, increasing the power of cross-validation of this study. Additionally, we are
currently in collaboration with the Yodh Lab to implement simultaneous optical
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spectroscopy of flow and metabolism in this animal model (133). Difficulty with light
penetration through the skull has kept this technique from working accurately in the past.
However, we recently have begun to drill through the skull to place fibers directly on the
dura. This should allow for accurate studies and create the possibility of a three-way
cross validation of optical data, BOLD/ASL data, and 17O2 inhalation.

We plan to further analyze the proposed model in Chapter 6 with an animal model of
altered metabolism. As mentioned above, a moderate hypothermia protocol may be
ideally suited to this task. It also may be possible to perform this experiment in our
hypermetabolic swine model, with the expectation that hyperoxic R1 enhancement will be
reduced upon DNP administration.

While many of these studies above have been performed in animal models, some of these
can be translated to human studies. For example, the experiments performed using a
swine model (Chapter 5) can be performed in humans, although metabolic alteration
methods other than DNP must be used (such as visual stimulation). A cross-validation
study using hyperoxic calibrated function MRI and

17

O2 inhalation would be ideal in

humans, because of the ability to localize and repeat cerebral stimulation paradigms.
Similarly, the experiments performed on rats in Chapter 6 can also be performed using
human subjects. The use of lower levels of CO2 would be necessary in this context, as
high levels are not well-tolerated even by healthy subjects (107). This study in humans
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may actually be easier than animal models, as testing our model against CMRO2 changes
can easily be achieved using functional MRI protocols. For the reasons discussed above,
the one exception where animal studies may be necessary are studies measuring T1a.

7.2 Summary of Dissertation
As presented in Chapter 1, interest in the use of inhaled oxygen as an intravascular
contrast agent has increased due to a number of attractive features. These include wide
availability, low cost, high tolerability, lack of contraindications, minimal physiologic
effects, and rapid wash-in and wash-out times of this contrast agent. Although numerous
applications using hyperoxia have emerged, its use as a quantitative MRI contrast agent
continues to be hampered by the lack of a complete understanding of the nature and
extent of its effects in vivo. This thesis has focused on several areas where crucial
mechanisms of hyperoxia contrast need further elucidation in vivo: (1) the effects of
gaseous and dissolved paramagnetic molecular oxygen on BOLD and ASL data, (2) the
degree and temporal characteristics CBF reduction during hyperoxia, (3) the use of
hyperoxia in quantitative measurements of metabolism with calibrated BOLD/ASL data,
and (4) the biophysical mechanisms of hyperoxic T1 contrast.

We have demonstrated that the paramagnetic effects of molecular oxygen significantly
complicate the analysis of BOLD-modulated hyperoxic contrast studies of the brain in
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Chapter 2. Negative signal changes that were observed in T2*-weighted images in the
frontal lobes, ventricles, and brain periphery suggested the influence of image distortions
and increased intravoxel dephasing from oxygen-induced susceptibility changes in and
around the upper airway. Static field changes during oxygen inhalation were shown to
scale with the main magnetic field strength and FiO2. Reducing FiO2 was shown to
reduce negative signal changes while still maintaining adequate BOLD contrast for
accurate CBV calculation.

Using measurements of phantoms and arterial blood in vivo, we demonstrated in Chapter
3 that T1a is well described by the linear combination of longitudinal relaxivities of
molecular oxygen and deoxyhemoglobin. We also found that when comparing brief and
graded hyperoxic inhalation paradigms, T1a changes rapidly with changing FiO2 and does
not change over time. In Chapter 4, we showed with simultaneous in vivo measurements
of T1a and CBF that measured reductions in CBF using ASL during hyperoxia are
dominated by T1a reduction during short term inhalation epochs. For longer hyperoxic
exposures, physiologic effects such as reduced action of nitric oxide seem to be the
dominant source of ASL signal reduction.

In Chapter 5, we demonstrated the feasibility of accurate CMRO2 measurements with
hyperoxia calibrated simultaneous BOLD/ASL data in a hypermetabolic animal model.
Although producing slightly different calibration measurements, hyperoxia and
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hypercapnia were shown to produce very similar results in detecting changes in CMRO2.
Finally, we found similar increases in CMRO2 using our hyperoxia calibrated
BOLD/ASL data as compared to measurements using 17O2 inhalation in the same animal
model.

We established a biophysical model of the relationship between hyperoxic R1
enhancement and blood flow, blood volume, and metabolism in Chapter 6. Our model
predicts that hyperoxic R1 enhancement increases with faster blood flow and less tissue
oxygen consumption, showing opposite behavior to BOLD contrast that is
complementary for differing physiological conditions. Isometabolic increases in CBF
were shown to be accurately described by the model, but testing this model in the setting
of altered metabolism will be necessary for its complete validation.

In conclusion, we hope that this work provides valuable knowledge and insights that
increase the accuracy and utility of hyperoxia as a quantitative MRI contrast agent. We
anticipate that this contrast agent will continue to play an expanding and invaluable role
in numerous clinical and research settings.
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